Quaker Chemical (KWR) 10-Q 28 Oct 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014
Document and Entity Information [Abstract]	'
Document Type	'10-Q
Document period end date	30-Sep-14
Amendment flag	'false
Document Fiscal Year Focus	'2014
Document Period Focus	'Q3
Current fiscal year end date	'--12-31
Entity central index key	'0000081362
Entity current reporting status	'Yes
Entity filer category	'Large Accelerated Filer
Entity registrant name	'Quaker Chemical Corporation
Entity voluntary filers	'No
Entity well known seasoned issuer	'No
Entity common stock shares outstanding	13,269,266

Condensed_Consolidated_Stateme

Condensed Consolidated Statement of Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement [Abstract]	'	'	'	'
Net Sales	$198,867	$184,059	$571,827	$545,098
Cost of goods sold	128,567	118,069	368,197	349,186
Gross profit	70,300	65,990	203,630	195,912
Selling, general and administrative expenses	49,747	47,183	142,759	139,901
Operating income	20,553	18,807	60,871	56,011
Other Income (Expense), net	914	-685	558	1,962
Interest Expense	-641	-717	-1,747	-2,223
Interest Income	642	267	1,990	665
Income Before Taxes and Equity in Net Income of Associated Companies	21,468	17,672	61,672	56,415
Taxes on income before equity in net income of associated companies	5,724	5,972	18,808	16,933
Income before equity in net income of associated companies	15,744	11,700	42,864	39,482
Equity in net income of associated companies	375	1,605	2,506	4,689
Net Income	16,119	13,305	45,370	44,171
Less: Net income attributable to noncontrolling interest	423	754	1,517	1,918
Net Income Attributable to Quaker Chemical Corporation	$15,696	$12,551	$43,853	$42,253
Per share data:	'	'	'	'
Basic Earnings Per Common Share	$1.18	$0.95	$3.31	$3.21
Diluted Earnings per Common Share	$1.18	$0.95	$3.31	$3.21
Dividends Declared	$0.30	$0.25	$0.85	$0.75

Condensed_Consolidated_Stateme1

Condensed Consolidated Statement of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Net Income	$16,119	$13,305	$45,370	$44,171
Currency Translation Adjustments	-11,655	2,272	-9,400	-3,674
Defined Benefit Retirement Plans	1,797	-180	2,956	1,688
Unrealized (Loss) Gain on Available-for-Sale Securities	-214	-333	-316	-616
Other Comprehensive Income (Loss)	-10,072	1,759	-6,760	-2,602
Comprehensive Income	6,047	15,064	38,610	41,569
Less: Comprehensive Income Attributable to Noncontrolling Interest	-177	-499	-1,470	-699
Comprehensive Income Attributable to Quaker Chemical Corporation	$5,870	$14,565	$37,140	$40,870

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheet (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets	'	'
Cash and cash equivalents	$64,221	$68,492
Accounts receivable, net	188,982	165,629
Inventories	'	'
Raw materials and supplies	40,348	37,063
Work-in-process and finished goods	40,186	34,494
Prepaid expenses and other current assets	19,818	23,169
Total current assets	353,555	328,847
Property, plant and equipment, at cost	233,371	233,865
Less accumulated depreciation	-149,575	-148,377
Net property, plant and equipment	83,796	85,488
Goodwill	70,053	58,151
Other intangible assets, net	59,301	31,272
Investments in associated companies	21,149	19,397
Deferred income taxes	21,996	24,724
Other assets	34,360	36,267
Total assets	644,210	584,146
Current liabilities	'	'
Short-term borrowings and current portion of long-term debt	571	1,395
Accounts and other payables	85,888	75,580
Accrued compensation	16,058	20,801
Other current liabilities	28,362	33,080
Total current liabilities	130,879	130,856
Long-term debt	62,009	17,321
Deferred income taxes	5,920	6,729
Other non-current liabilities	78,391	84,544
Total liabilities	277,199	239,450
Equity	'	'
Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding 2014 - 13,269,266 shares; 2013 - 13,196,140 shares	13,269	13,196
Capital in excess of par value	96,717	99,038
Retained earnings	290,876	258,285
Accumulated Other Comprehensive Loss	-41,413	-34,700
Total Quaker shareholders' equity	359,449	335,819
Noncontrolling interest	7,562	8,877
Total equity	367,011	344,696
Total liabilities and equity	$644,210	$584,146

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheet (Parentheticals) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Statement Of Financial Position [Abstract]	'	'
Common Stock Par Value	$1	$1
Common Stock, Shares Authorized	30,000,000	30,000,000
Common Stock, Shares, Issued	13,269,266	13,196,140

Condensed_Consolidated_Stateme2

Condensed Consolidated Statement of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities	'	'
Net Income	$45,370	$44,171
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation	9,154	9,219
Amortization	2,754	2,621
Equity in undistributed earnings of associated companies, net of dividends	-2,306	-2,525
Deferred compensation and other, net	1,672	-50
Stock-based compensation	3,959	3,133
Gain on Disposal of Property, Plant and Equipment	-125	193
Insurance settlement realized	-1,214	-731
Pension and other postretirement benefits	178	-561
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:	'	'
Accounts receivable	-23,061	-13,222
Inventories	-9,143	-4,569
Prepaid expenses and other current assets	1,332	1,017
Accounts payable and accrued liabilities	9,470	13,256
Net cash provided by operating activities	38,040	51,952
Cash flows from investing activities	'	'
Investments in property, plant and equipment	-8,376	-7,330
Payments related to acquisitions, net of cash acquired	-51,947	-2,478
Proceeds from disposition of assets	178	391
Interest earned on insurance settlements	34	40
Change in restricted cash, net	1,180	691
Net cash used in investing activities	-58,931	-8,686
Cash flows from financing activities	'	'
Proceeds from long-term debt	45,000	0
Repayment of long-term debt	-1,106	-12,289
Dividends paid	-10,580	-9,721
Stock options exercised, other	-194	-510
Excess Tax Benefit Related to Stock Option Exercises, Cash Flow	430	815
Purchase of a noncontrolling interest in an affiliate	-7,422	0
Payment of acquisition-related earnout liability	-4,709	0
Distributions to noncontrolling affiliate shareholders	-1,806	-30
Net cash provided by (used in) financing activities	19,613	-21,735
Effect of exchange rate changes on cash	-2,993	-133
Net (Decrease) Increase in Cash and Cash Equivalents	-4,271	21,398
Cash and cash equivalents at beginning of period	68,492	32,547
Cash and cash equivalents at end of period	64,221	53,945
Other Noncash Investing And Financing Items [Abstract]	'	'
Accrued Property, Plant and Equipment Purchases	$0	$1,178

Condensed_Financial_Informatio

Condensed Financial Information	9 Months Ended
	Sep. 30, 2014
Organization Consolidation And Presentation Of Financial Statements [Abstract]	'
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	'
	Note 1 – Condensed Financial Information
	The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial reporting and the United States Securities and Exchange Commission regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments (consisting only of normal recurring adjustments, except as discussed below) which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. During the first quarter of 2014, the Company revised its Consolidated Balance Sheet for December 31, 2013 with a $335 reduction to retained earnings and a corresponding increase to its long-term deferred tax liability, relating to an adjustment that would have occurred when the Company adopted the equity method of accounting for its interest in a captive insurance equity affiliate. Certain other reclassifications of prior year data have been made to improve comparability. The results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company's Annual Report filed on Form 10-K for the year ended December 31, 2013.
	Venezuela currently operates three local exchange markets to obtain U.S. Dollars: the CADIVI, SICAD I and SICAD II. Under generally accepted principles in the United States, Venezuela's economy is considered to be hyper inflationary, so, accordingly, all gains and losses resulting from the remeasurement of the Company's Venezuelan equity affiliate Kelko Quaker Chemical, S.A. (“Kelko”) to the CADIVI published exchange are required to be recorded directly to the Condensed Consolidated Statement of Income. As of September 30, 2014, the Company has a $1,644 investment in Kelko, which is currently valued at the CADIVI exchange rate. The Company currently does not have access to trade on the SICAD I exchange rate. During the second quarter of 2014, the Company recorded a charge of $321, or $0.02 per diluted share, related to the conversion of certain Venezuelan Bolivar Fuerte to U.S. Dollars on the SICAD II exchange. During the first quarter of 2013, the Venezuelan Government announced a devaluation of the Bolivar Fuerte, which resulted in a charge of $357, or $0.03 per diluted share.
	During 2002 and 2003, the Company's Netherlands and Italian subsidiaries paid excise taxes on mineral oil sales in Italy for a total amount of approximately $2,000. Alleging that the mineral oil excise tax was contrary to European Union directives, the subsidiaries filed with the Customs' Authority of Milan (“Customs Office” or “Office”) requests to obtain a refund of the above-mentioned amount. The parties appealed rulings to various levels of tax courts up through the Supreme Court of Italy. In March 2012, the Supreme Court rejected the appeal of the Customs Office, ruling in favor of the subsidiaries and granting a refund for the amounts requested. After filing an enforcement action, the Company collected approximately $2,057, along with approximately $483 of interest, in the second quarter of 2013. This amount was recorded as other income on the Company's Condensed Consolidated Statement of Income in the second quarter of 2013.
	As part of the Company's chemical management services, certain third-party product sales to customers are managed by the Company. Where the Company acts as the principal, revenue is recognized on a gross reporting basis at the selling price negotiated with customers. Where the Company acts as an agent, such revenue is recorded using net reporting as service revenues, at the amount of the administrative fee earned by the Company for ordering the goods. Third-party products transferred under arrangements resulting in net reporting totaled $11,829 and $33,328 for the three and nine months ended September 30, 2014, respectively. Third-party products transferred under arrangements resulting in net reporting totaled $10,950 and $30,288 for the three and nine months ended September 30, 2013, respectively.

Recently_Issued_Accounting_Sta

Recently Issued Accounting Standards	9 Months Ended
	Sep. 30, 2014
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]	'
Description of New Accounting Pronouncements Not yet Adopted [Text Block]	'
	Note 2 – Recently Issued Accounting Standards
	The Financial Accounting Standards Board (“FASB”) issued an accounting standard in August 2014 to outline specific requirements for an entity to evaluate its ability to continue as a going concern. The new guidance requires a company to assess whether certain conditions or events exist at the date financial statements are issued that may raise substantial doubt about its ability to continue as a going concern for the next year. If a company concludes that it is not able to continue as a going concern and it is not able to mitigate the conditions and events that resulted in the entity's ability to continue as a going concern, footnote disclosure is required. The guidance is effective for the annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company is currently evaluating the effects of this guidance, but does not expect a material impact.
	The FASB issued an accounting standard update in May 2014 regarding the accounting for and disclosures of revenue recognition. Specifically, the update outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers, which will be common to both GAAP and International Financial Reporting Standards (“IFRS”). The model focuses on revenue recognition to reflect the actual consideration to which the entity expects to be entitled in exchange for the goods or services defined in the contract, including multiple performance obligations. The guidance is effective for annual and interim periods beginning after December 15, 2016, which allows for full retrospective adoption of prior period data or a modified retrospective adoption whereby the cumulative past effects are recorded and disclosed in the current period. Early adoption is not permitted. Currently, the Company is evaluating the effect that the guidance may have on its financial statements.

Out_of_Period_Adjustment

Out of Period Adjustment	9 Months Ended
	Sep. 30, 2014
Accounting Changes and Error Corrections [Abstract]	'
Accounting Changes and Error Corrections [Text Block]	'
	Note 3 – Out-of-Period Adjustment
	During 2012, the Company reassessed its ability to significantly influence the operating and financial policies of its captive insurance equity affiliate, Primex. Based on its ownership percentage and other factors, the Company determined that, during 2012, the Company obtained the ability to significantly influence Primex and, as a result, changed its method of accounting from the cost to equity method. During the first quarter of 2013, the Company identified errors in Primex's estimated 2012 financial statements, which primarily related to a reinsurance contract held by Primex. The identified errors resulted in a cumulative $1,038 understatement of the Company's equity in net income from associated companies for the year ended December 31, 2012. The Company corrected the errors related to Primex in the first quarter of 2013, which had the net effect of increasing equity in net income from associated companies by $1,038 for the three months ended March 31, 2013. The Company did not believe this adjustment was material to its consolidated financial statements for the years ended December 31, 2012 or December 31, 2013 and, therefore, did not restate any prior period amounts.

Business_Segments

Business Segments	9 Months Ended
	Sep. 30, 2014
Segment Reporting Measurement Disclosures [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	Note 4 – Business Segments
	The Company's reportable operating segments are organized by geography as follows: (i) North America, (ii) Europe, Middle East and Africa (“EMEA”), (iii) Asia/Pacific and (iv) South America. Operating earnings, excluding indirect operating expenses, for the Company's reportable operating segments are comprised of revenues less costs of goods sold and SG&A directly related to the respective regions' product sales. The indirect operating expenses consist of SG&A related expenses that are not directly attributable to the product sales of each respective reportable operating segment. Other items not specifically identified with the Company's reportable operating segments include interest expense, interest income, license fees from non-consolidated affiliates and other income (expense).
	The following table presents information about the Company's reported segments for the three and nine months ended September 30, 2014 and September 30, 2013:
			Three Months Ended				Nine Months Ended
			September 30,				September 30,
			2014		2013		2014		2013
	Net sales
		North America	$	87,909	$	79,602	$	247,137	$	231,111
		EMEA		49,352		44,452		148,769		140,314
		Asia/Pacific		49,601		44,063		136,661		124,593
		South America		12,005		15,942		39,260		49,080
	Total net sales		$	198,867	$	184,059	$	571,827	$	545,098
	Operating earnings, excluding indirect operating expenses
		North America	$	17,771	$	15,203	$	51,350	$	46,238
		EMEA		8,589		6,781		24,794		22,332
		Asia/Pacific		11,925		11,214		32,064		31,612
		South America		883		2,598		3,281		7,830
	Total operating earnings, excluding indirect operating expenses			39,168		35,796		111,489		108,012
	Indirect operating expenses			-17,489		-16,131		-47,864		-49,380
	Amortization expense			-1,126		-858		-2,754		-2,621
	Consolidated operating income			20,553		18,807		60,871		56,011
	Other income (expense), net			914		-685		558		1,962
	Interest expense			-641		-717		-1,747		-2,223
	Interest income			642		267		1,990		665
	Consolidated income before taxes and equity in net income of associated companies		$	21,468	$	17,672	$	61,672	$	56,415
	Inter-segment revenue for the three and nine months ended September 30, 2014 was $2,605 and $6,411 for North America, $5,801 and $16,582 for EMEA, $127 and $329 for Asia/Pacific and zero for South America, respectively. Inter-segment revenue for the three and nine months ended September 30, 2013 was $2,486 and $7,333 for North America, $5,771 and $15,427 for EMEA, $58 and $363 for Asia/Pacific and zero for South America, respectively. However, all inter-segment transactions have been eliminated from each reportable operating segment's net sales and earnings for all periods presented above.

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2014
Share Based Compensation [Abstract]	'
Disclosure Of Compensation Related Costs Share Based Payments [Text Block]	'
	Note 5 – Stock-Based Compensation
	The Company recognized the following share-based compensation expense in selling, general and administrative expenses in its Condensed Consolidated Statement of Income for the three and nine months ended September 30, 2014 and the three and nine months ended September 30, 2013:
				Three Months Ended						Nine Months Ended
				September 30,						September 30,
				2014			2013			2014			2013
		Stock options		$	171		$	140		$	492		$	378
		Nonvested stock awards and restricted stock units			593			461			1,758			1,372
		Employee stock purchase plan			18			17			54			43
		Non-elective and elective 401(k) matching contribution in stock			413			347			1,561			1,283
		Director stock ownership plan			32			16			94			57
		Total share-based compensation expense		$	1,227		$	981		$	3,959		$	3,133
	As of September 30, 2014 and September 30, 2013, the Company recorded $430 and $815, respectively, of excess tax benefits in capital in excess of par value on its Condensed Consolidated Balance Sheets related to stock option exercises. The Company's estimated taxes payable was sufficient to fully recognize these benefits as cash inflows from financing activities in its Condensed Consolidated Statement of Cash Flows, which represented the Company's estimate of cash savings through the nine months ended September 30, 2014 and September 30, 2013, respectively.
	Stock option activity under all plans is as follows:
									Weighted
									Average
					Weighted Average				Remaining
			Number of		Exercise Price per				Contractual
			Shares		Share				Term (years)
	Options outstanding at December 31, 2013		75,251		$	44.49
		Options granted	37,048			73.47
		Options exercised	-3,292			42.24
	Options outstanding at September 30, 2014		109,007		$	54.41				5.1
	Options exercisable at September 30, 2014		40,628		$	39.76				4
	As of September 30, 2014, the total intrinsic value of options outstanding was approximately $2,007, and the total intrinsic value of exercisable options was $1,330. Intrinsic value is calculated as the difference between the current market price of the underlying security and the strike price of a related option.
	A summary of the Company's outstanding stock options at September 30, 2014 is as follows:
									Weighted		Weighted			Number	Weighted
							Number		Average		Average			Exercisable	Average
	Range of						Outstanding		Contractual		Exercise			at	Exercise
	Exercise Prices						at 9/30/2014		Life		Price			9/30/14	Price
	$	0	-		$	10	0		0		$	0		0	$	0
	$	10.01	-		$	20	6,155		2.3			18.82		6,155		18.82
	$	20.01	-		$	30	0		0			0		0		0
	$	30.01	-		$	40	35,020		4.1			37.87		23,954		37.75
	$	40.01	-		$	50	2,192		4.7			46.21		1,462		46.21
	$	50.01	-		$	60	28,592		5.4			58.26		9,057		58.26
	$	60.01	-		$	70	0		0			0		0		0
	$	70.01	-		$	80	37,048		6.4			73.47		0		0
							109,007		5.1			54.41		40,628		39.76
	As of September 30, 2014, unrecognized compensation expense related to options granted during 2012 was $91, for options granted during 2013 was $304 and for options granted in 2014 was $658.
	During the first quarter of 2014, the Company granted stock options under its LTIP plan that are subject only to time vesting over a three-year period. For the purposes of determining the fair value of stock option awards, the Company uses the Black-Scholes option pricing model and the assumptions set forth in the table below:
			2014
		Number of options granted	37,048
		Dividend yield	2	%
		Expected volatility	43.34	%
		Risk-free interest rate	1.22	%
		Expected term (years)	4
	Approximately $68 and $159 of expense was recorded on these options during the three and nine months ended September 30, 2014, respectively. The fair value of these awards is amortized on a straight-line basis over the vesting period of the awards.
	Activity of nonvested shares granted under the Company's LTIP plan is shown below:
						Weighted
						Average Grant
				Number of		Date Fair Value
				Shares		(per share)
		Nonvested awards, December 31, 2013		115,984		$	47.27
			Granted	55,258		$	73.8
			Vested	-42,223		$	40.51
			Forfeited	-3,895		$	37.01
		Nonvested awards, September 30, 2014		125,124		$	61.59
	The fair value of the nonvested stock is based on the trading price of the Company's common stock on the date of grant. The Company adjusts the grant date fair value for expected forfeitures based on historical experience for similar awards. As of September 30, 2014, unrecognized compensation expense related to these awards was $4,916 to be recognized over a weighted average remaining period of 2.37 years.
	Activity of nonvested restricted stock units granted under the Company's LTIP plan is shown below:
						Weighted
						Average Grant
				Number of		Date Fair Value
				units		(per unit)
	Nonvested awards, December 31, 2013		4,018		$	49.71
		Granted	3,140		$	75.52
	Nonvested awards, September 30, 2014		7,158		$	61.03
The fair value of the nonvested restricted stock units is based on the trading price of the Company's common stock on the date of grant. The Company adjusts the grant date fair value for expected forfeitures based on historical experience for similar awards. As of September 30, 2014, unrecognized compensation expense related to these awards was $243 to be recognized over a weighted average remaining period of 2.01 years.
Employee Stock Purchase Plan
In 2000, the Board adopted an Employee Stock Purchase Plan (“ESPP”) whereby employees may purchase Company stock through a payroll deduction plan. Purchases are made from the plan and credited to each participant's account at the end of each month, the “Investment Date.” The purchase price of the stock is 85% of the fair market value on the Investment Date. The plan is compensatory and the 15% discount is expensed on the Investment Date. All employees, including officers, are eligible to participate in this plan. A participant may withdraw all uninvested payment balances credited to a participant's account at any time. An employee whose stock ownership of the Company exceeds five percent of the outstanding common stock is not eligible to participate in this plan.
2013 Director Stock Ownership Plan
In March 2013, the Company adopted the 2013 Director Stock Ownership Plan (the “Plan”), subject to the approval by the Company's shareholders at the annual meeting, to encourage the Directors to increase their investment in the Company. The Plan was approved at the Company's May 2013 shareholders' meeting. The Plan authorizes the issuance of up to 75,000 shares of Quaker common stock in accordance with the terms of the Plan in payment of all or a portion of the annual cash retainer payable to each of the Company's non-employee directors in 2013 and subsequent years during the term of the Plan. Under the Plan, each director who, on May 1st of the applicable calendar year, owns less than 400% of the annual cash retainer for the applicable calendar year, divided by the average of the closing price of a share of Quaker Common Stock as reported by the composite tape of the New York Stock Exchange for the previous calendar year (the “Threshold Amount”), is required to receive 75% of the annual cash retainer in Quaker common stock and 25% of the retainer in cash, unless the director elects to receive a greater percentage of Quaker common stock (up to 100%) of the annual cash retainer for the applicable year. Each director who owns more than the Threshold Amount may elect to receive common stock in payment of a percentage (up to 100%) of the annual cash retainer. The annual retainer is $50 and the retainer payment date is June 1. The Plan was adopted in order to replace the 2003 Director Stock Ownership Plan, which expired in May 2013.

Pension_and_Postretirement_Ben

Pension and Postretirement Benefits	9 Months Ended
	Sep. 30, 2014
General Discussion Of Pension And Other Postretirement Benefits [Abstract]	'
Pension And Other Postretirement Benefits Disclosure [Text Block]	'
	Note 6 – Pension and Other Postretirement Benefits
	The components of net periodic benefit cost for the three and nine months ended September 30, 2014 and September 30, 2013 are as follows:
		Three Months Ended September 30,								Nine Months Ended September 30,
						Other								Other
						Postretirement								Postretirement
		Pension Benefits				Benefits				Pension Benefits				Benefits
			2014		2013		2014		2013		2014		2013		2014		2013
	Service cost	$	716	$	789	$	5	$	9	$	2,186	$	2,355	$	15	$	26
	Interest cost and other		1,506		1,394		58		46		4,567		4,172		174		138
	Expected return on plan assets		-1,588		-1,476		0		0		-4,796		-4,417		0		0
	Actuarial loss amortization		763		989		16		8		2,311		2,961		48		24
	Prior service cost amortization		-21		23		0		0		830		155		0		0
	Net periodic benefit cost	$	1,376	$	1,719	$	79	$	63	$	5,098	$	5,226	$	237	$	188
	During 2013, it was discovered that the Company's subsidiary in the United Kingdom did not appropriately amend a trust for a legacy change in its pension scheme, as it related to a past retirement age equalization law. Given the lack of an official deed to the pension trust, the effective date of the change to the Subsidiary's pension scheme differed from the Company's historical beliefs, but the extent of the potential exposure was not estimable. In the first quarter of 2014, the Company recorded costs of $902, or $0.05 per diluted share, related to prior service cost and interest cost, to appropriately reflect the past plan amendment related to the retirement age equalization law.
	Employer Contributions:
	The Company previously disclosed in its financial statements for the year ended December 31, 2013, that it expected to make minimum cash contributions of $6,172 to its pension plans and $607 to its other postretirement benefit plan in 2014. However, the Company exercised its option under the provisions of the Moving Ahead for Progress in the 21st Century Act (“MAP-21”) to reduce its current contributions. Currently, the Company expects to make minimum cash contributions of $5,257 to its pension plans and $607 to its other postretirement benefit plan in 2014. As of September 30, 2014, $4,757 and $432 of contributions had been made to the Company's pension plans and its other postretirement benefit plans, respectively.

Other_Income_Expense

Other Income (Expense)	9 Months Ended
	Sep. 30, 2014
Other Income And Expenses [Abstract]	'
Other Income And Other Expense Disclosure [Text Block]	'
	Note 7 – Other Income (Expense)
	Other Income (Expense) includes:
			Three Months Ended				Nine Months Ended
			September 30,				September 30,
			2014		2013		2014		2013
	Change in fair value of acquisition-related earnout liability		$	0	$	0	$	0	$	-675
	Cost streamlining initiative			0		-211		0		-211
	Income from third party license fees			181		168		736		716
	Net foreign currency exchange gains (losses)			160		-635		-824		-840
	Net gain on fixed asset disposals			25		29		130		267
	Non-income tax refunds			531		0		531		2,669
	Other non-operating income			88		27		152		193
	Other non-operating expense			-71		-63		-167		-157
		Total other income (expense), net	$	914	$	-685	$	558	$	1,962

Income_Taxes_and_Uncertain_Tax

Income Taxes and Uncertain Tax Positions	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	Note 8 – Income Taxes and Uncertain Income Tax Positions
	The Company's effective tax rate for the first nine months of 2014 of 30.5% was higher than the first nine months of 2013 effective tax rate of 30.0%. Both effective tax rates reflect decreases in reserves for uncertain tax positions due to the expiration of applicable statutes of limitations for certain tax years of approximately $0.06 and $0.13 per diluted share for the nine months ended September 30, 2014 and September 30, 2013, respectively. The earnings per diluted share impact related to changes in uncertain tax positions was lower in the current year. However, this impact was offset by recording tax expense at the statutory tax rate of one of the Company's entities in its Asia/Pacific region, where it was recording tax expense at its statutory tax rate of 25% while it awaited recertification of a concessionary tax rate.
	As of September 30, 2014, the Company's cumulative liability for gross unrecognized tax benefits was $11,317. At December 31, 2013, the Company's cumulative liability for gross unrecognized tax benefits was $12,596.
	The Company continues to recognize interest and penalties associated with uncertain tax positions as a component of taxes on income before equity in net income of associated companies in its Condensed Consolidated Statement of Income. The Company recognized $(6) and $(64) for interest and $(99) and $(1) for penalties on its Condensed Consolidated Statement of Income for the three and nine months ended September 30, 2014, respectively, and recognized $39 and $(294) for interest and $101 and $342 for penalties on its Condensed Consolidated Statement of Income for the three and nine months ended September 30, 2013, respectively. As of September 30, 2014, the Company had accrued $1,900 for cumulative interest and $1,939 for cumulative penalties, compared to $2,108 for cumulative interest and $2,100 for cumulative penalties at December 31, 2013.
	During the three months ended September 30, 2014, the Company recognized a decrease in its cumulative liability for gross unrecognized tax benefits of $802 due to the expiration of the applicable statutes of limitations for certain tax years. During the three months ended September 30, 2013, the Company recognized a decrease in its cumulative liability for gross unrecognized tax benefits of $472 due to the expiration of the applicable statutes of limitations for certain tax years.
	During the nine months ended September 30, 2014, the Company recognized a decrease in its cumulative liability for gross unrecognized tax benefits of $1,877 due to the expiration of the applicable statutes of limitations for certain tax years. During the nine months ended September 30, 2013, the Company recognized a decrease in its cumulative liability for gross unrecognized tax benefits of $2,167 due to the expiration of the applicable statutes of limitations for certain tax years.
	The Company estimates that during the year ending December 31, 2014 it will reduce its cumulative liability for gross unrecognized tax benefits by approximately $1,900 to $2,000 due to the expiration of the statute of limitations with regard to certain tax positions. This estimated reduction in the cumulative liability for unrecognized tax benefits does not consider any increase in liability for unrecognized tax benefits with regard to existing tax positions or any increase in cumulative liability for unrecognized tax benefits with regard to new tax positions for the year ending December 31, 2014.
	The Company and its subsidiaries are subject to U.S. Federal income tax, as well as the income tax of various state and foreign tax jurisdictions. Tax years that remain subject to examination by major tax jurisdictions include Brazil from 2000, the Netherlands from 2008, the United Kingdom from 2009, Spain, China and Italy from 2010, the United States from 2011, and various domestic state tax jurisdictions from 1993.
	During the second quarter of 2012, the Italian tax authorities initiated a transfer pricing audit of the Company's Italian subsidiary. On July 7, 2012, the Company received a preliminary tax report related to this transfer pricing audit, which proposed several adjustments to the taxable income of the subsidiary. During the fourth quarter of 2012, the Company's Italian subsidiary received an assessment for the tax year 2007, which the Company appealed during the first quarter of 2013. On September 16, 2013, the Provincial Tax Court of Varese delivered a decision confirming the Italian tax authorities' proposed adjustment to the taxable income of the subsidiary, but denying the proposed assessment of penalties. On January 24, 2014, the Company's Italian subsidiary appealed the decision of the Provincial Tax Court of Varese. On March 7, 2014, the Italian tax authorities appealed the decision of the Provincial Tax Court denying the assessment of penalties.
	On November 29, 2013, the Italian tax authorities issued a tax assessment for the tax year 2008, raising identical issues as the assessment for 2007, noted above. On March 28, 2014, the Company filed an appeal with the Provincial Tax Court of Varese. The Company filed a request for competent authority relief between the Italian and Dutch tax authorities, and between the Italian and Spanish tax authorities.
	On August 4, 2014, the Italian tax authorities issued a tax assessment for the tax year 2009, raising identical issues as the assessments for 2007 and 2008, noted above.
	Related to each of the above events, the Company and outside counsel believe we should prevail on the merits of each case.  Therefore, the Company does not believe it has any exposures warranting an uncertain tax position reserve as of September 30, 2014.

Earnings_Per_Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	Note 9 – Earnings Per Share
	The following table summarizes earnings per share calculations for the three and nine months ended September 30, 2014 and September 30, 2013:
			Three Months Ended				Nine Months Ended
				September 30,				September 30,
			2014		2013		2014		2013
	Basic earnings per common share
		Net income attributable to Quaker Chemical Corporation	$	15,696	$	12,551	$	43,853	$	42,253
		Less: income allocated to participating securities		-140		-109		-385		-358
		Net income available to common shareholders	$	15,556	$	12,442	$	43,468	$	41,895
		Basic weighted average common shares outstanding		13,133,668		13,062,417		13,114,553		13,034,289
	Basic earnings per common share		$	1.18	$	0.95	$	3.31	$	3.21
	Diluted earnings per common share
		Net income attributable to Quaker Chemical Corporation	$	15,696	$	12,551	$	43,853	$	42,253
		Less: income allocated to participating securities		-140		-109		-384		-357
		Net income available to common shareholders	$	15,556	$	12,442	$	43,469	$	41,896
		Basic weighted average common shares outstanding		13,133,668		13,062,417		13,114,553		13,034,289
		Effect of dilutive securities		22,673		22,488		21,147		25,909
		Diluted weighted average common shares outstanding		13,156,341		13,084,905		13,135,700		13,060,198
	Diluted earnings per common share		$	1.18	$	0.95	$	3.31	$	3.21
	The following number of stock options and restricted stock units are not included in diluted earnings per share since the effect would have been anti-dilutive: 6,146 and 2,858 for the three months ended September 30, 2014 and September 30, 2013, respectively, and 5,254 and 4,118 for the nine months ended September 30, 2014 and September 30, 2013, respectively.

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2014
Goodwill And Intangible Assets Disclosure [Abstract]	'
Goodwill And Intangible Assets Disclosure [Text Block]	'
	Note 10 – Goodwill and Other Intangible Assets
	The Company completed its annual impairment assessment as of the end of the third quarter of 2014 and no impairment charge was warranted. The estimated fair value of each of the Company's reporting units substantially exceeded its carrying value, with none of the Company's reporting units at risk for failing step one of the goodwill impairment test. In addition, the Company has recorded no impairment charges in the past.
	Changes in the carrying amount of goodwill for the nine months ended September 30, 2014 were as follows:
			North									South
			America			EMEA			Asia/Pacific			America			Total
	Balance as of December 31, 2013		$	28,127		$	11,184		$	15,018		$	3,822		$	58,151
		Goodwill additions		13,429			0			0			0			13,429
		Currency translation adjustments		-611			-341			-458			-117			-1,527
	Balance as of September 30, 2014		$	40,945		$	10,843		$	14,560		$	3,705		$	70,053
	Gross carrying amounts and accumulated amortization for definite-lived intangible assets as of September 30, 2014 and December 31, 2013 are as follows:
				Gross Carrying						Accumulated
				Amount						Amortization
		Definite-lived intangible assets		2014			2013			2014			2013
			Customer lists and rights to sell	$	53,894		$	33,559		$	11,812		$	10,221
			Trademarks and patents		6,628			6,838			3,628			3,202
			Formulations and product technology		15,338			5,808			3,968			3,709
			Other		6,540			5,544			4,791			4,445
			Total	$	82,400		$	51,749		$	24,199		$	21,577
	The Company recorded $2,754 and $2,621 of amortization expense in the nine months ended September 30, 2014 and September 30, 2013, respectively. Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:
		For the year ended December 31, 2014	$	4,198
		For the year ended December 31, 2015	$	5,777
		For the year ended December 31, 2016	$	5,302
		For the year ended December 31, 2017	$	4,643
		For the year ended December 31, 2018	$	4,619
		For the year ended December 31, 2019	$	4,543
	The Company has two indefinite-lived intangible assets totaling $1,100 for trademarks at September 30, 2014.

Debt

Debt	9 Months Ended
	Sep. 30, 2014
Debt [Abstract]	'
Debt Disclosure [Text Block]	'
	Note 11 – Debt
	The Company's primary credit line is a $300,000 syndicated multicurrency credit agreement with Bank of America, N.A. (administrative agent) and certain other major financial institutions, which matures in June 2018. The maximum amount available under this facility can be increased to $400,000 at the Company's option if the lenders agree and the Company satisfies certain conditions. Access to this facility is dependent on meeting certain financial, acquisition and other covenants, but primarily depends on the Company's consolidated leverage ratio calculation, which cannot exceed 3.50 to 1. At September 30, 2014 and December 31, 2013, the consolidated leverage ratio was below 1.0 to 1 and the Company was also in compliance with all of the facility's other covenants. At September 30, 2014, the Company had approximately $45,000 outstanding under this facility. At December 31, 2013, the Company had no borrowings outstanding under this facility.

Equity_and_Noncontrolling_Inte

Equity and Noncontrolling Interest	9 Months Ended
	Sep. 30, 2014
Stockholders Equity [Abstract]	'
Stockholders Equity Note Disclosure [Text Block]	'
	Note 12 – Equity and Noncontrolling Interest
	The following table presents the changes in equity and noncontrolling interest for the three and nine months ended September 30, 2014 and September 30, 2013:
													Accumulated
							Capital in						Other
				Common			Excess of			Retained			Comprehensive		Noncontrolling
				Stock			Par Value			Earnings			Loss		Interest		Total
	Balance at June 30, 2014			$	13,242		$	95,508		$	279,161		$	-31,587	$	8,386	$	364,710
		Net income			0			0			15,696			0		423		16,119
		Amounts reported in other comprehensive income			0			0			0			-9,826		-246		-10,072
		Dividends ($0.30 per share)			0			0			-3,981			0		0		-3,981
		Distributions to noncontrolling affiliate shareholders			0			0			0			0		-1,149		-1,149
		Acquisition of noncontrolling interest			0			7			0			0		148		155
		Share issuance and equity-based compensation plans			27			1,039			0			0		0		1,066
		Excess tax benefit from stock option exercises			0			163			0			0		0		163
	Balance at September 30, 2014			$	13,269		$	96,717		$	290,876		$	-41,413	$	7,562	$	367,011
	Balance at June 30, 2013			$	13,168		$	97,085		$	238,580		$	-45,252	$	8,776	$	312,357
		Net income			0			0			12,551			0		754		13,305
		Amounts reported in other comprehensive income			0			0			0			2,014		-255		1,759
		Dividends ($0.25 per share)			0			0			-3,298			0		0		-3,298
		Distributions to noncontrolling affiliate shareholders			0			0			0			0		-30		-30
		Share issuance and equity-based compensation plans			19			368			0			0		0		387
		Excess tax benefit from stock option exercises			0			363			0			0		0		363
	Balance at September 30, 2013			$	13,187		$	97,816		$	247,833		$	-43,238	$	9,245	$	324,843
													Accumulated
							Capital in						Other
				Common			Excess of			Retained			Comprehensive		Noncontrolling
				Stock			Par Value			Earnings			Loss		Interest		Total
	Balance at December 31, 2013			$	13,196		$	99,038		$	258,285		$	-34,700	$	8,877	$	344,696
		Net income			0			0			43,853			0		1,517		45,370
		Amounts reported in other comprehensive income			0			0			0			-6,713		-47		-6,760
		Dividends ($0.85 per share)			0			0			-11,262			0		0		-11,262
		Distributions to noncontrolling affiliate shareholders			0			0			0			0		-1,806		-1,806
		Acquisition of noncontrolling interest			0			-6,443			0			0		-979		-7,422
		Share issuance and equity-based compensation plans			73			3,692			0			0		0		3,765
		Excess tax benefit from stock option exercises			0			430			0			0		0		430
	Balance at September 30, 2014			$	13,269		$	96,717		$	290,876		$	-41,413	$	7,562	$	367,011
	Balance at December 31, 2012			$	13,095		$	94,470		$	215,390		$	-41,855	$	8,576	$	289,676
		Net income			0			0			42,253			0		1,918		44,171
		Amounts reported in other comprehensive income			0			0			0			-1,383		-1,219		-2,602
		Dividends ($0.745 per share)			0			0			-9,810			0		0		-9,810
		Distributions to noncontrolling affiliate shareholders			0			0			0			0		-30		-30
		Share issuance and equity-based compensation plans			92			2,531			0			0		0		2,623
		Excess tax benefit from stock option exercises			0			815			0			0		0		815
	Balance at September 30, 2013			$	13,187		$	97,816		$	247,833		$	-43,238	$	9,245	$	324,843
	The following tables show the reclassifications from and resulting balances of accumulated other comprehensive loss for the three and nine months ended September 30, 2014 and September 30, 2013:
									Unrealized
			Currency			Defined			gain (loss) in
			translation			benefit			available-for-
			adjustments			pension plans			sale securities			Total
	Balance at June 30, 2014		$	3,208		$	-36,274		$	1,479		$	-31,587
	Other comprehensive (loss) income before reclassifications			-11,409			1,698			-24			-9,735
	Amounts reclassified from accumulated other comprehensive loss			0			759			-300			459
	Current period other comprehensive (loss) income			-11,409			2,457			-324			-9,276
	Related tax amounts			0			-660			110			-550
	Net current period other comprehensive (loss) income			-11,409			1,797			-214			-9,826
	Balance at September 30, 2014		$	-8,201		$	-34,477		$	1,265		$	-41,413
	Balance at June 30, 2013		$	-1,646		$	-45,046		$	1,440		$	-45,252
	Other comprehensive income (loss) before reclassifications			2,527			-1,016			494			2,005
	Amounts reclassified from accumulated other comprehensive loss			0			1,019			-998			21
	Current period other comprehensive income (loss)			2,527			3			-504			2,026
	Related tax amounts			0			-183			171			-12
	Net current period other comprehensive income (loss)			2,527			-180			-333			2,014
	Balance at September 30, 2013		$	881		$	-45,226		$	1,107		$	-43,238
								Unrealized
		Currency			Defined			gain (loss) in
		translation			benefit			available-for-
		adjustments			pension plans			sale securities			Total
Balance at December 31, 2013		$	1,152		$	-37,433		$	1,581		$	-34,700
Other comprehensive (loss) income before reclassifications			-9,353			1,842			1,481			-6,030
Amounts reclassified from accumulated other comprehensive loss			0			2,290			-1,959			331
Current period other comprehensive (loss) income			-9,353			4,132			-478			-5,699
Related tax amounts			0			-1,176			162			-1,014
Net current period other comprehensive (loss) income			-9,353			2,956			-316			-6,713
Balance at September 30, 2014		$	-8,201		$	-34,477		$	1,265		$	-41,413
Balance at December 31, 2012		$	3,336		$	-46,914		$	1,723		$	-41,855
Other comprehensive (loss) income before reclassifications			-2,455			-468			1,353			-1,570
Amounts reclassified from accumulated other comprehensive loss			0			3,140			-2,286			854
Current period other comprehensive (loss) income			-2,455			2,672			-933			-716
Related tax amounts			0			-984			317			-667
Net current period other comprehensive (loss) income			-2,455			1,688			-616			-1,383
Balance at September 30, 2013		$	881		$	-45,226		$	1,107		$	-43,238
Approximately 30% and 70% of the amounts reclassified from accumulated other comprehensive loss to the Condensed Consolidated Statement of Income for defined benefit retirement plans during the three and nine months ended September 30, 2014 and September 30, 2013 were recorded in cost of goods sold and SG&A, respectively. See Note 6 of Notes to Condensed Consolidated Financial Statements for further information. All reclassifications related to unrealized gain (loss) in available-for-sale securities relate to the Company's equity interest in a captive insurance company and are recorded in equity in net income of associated companies. The amounts reported in other comprehensive income for noncontrolling interest are related to currency translation adjustments.

Business_Acquisitions

Business Acquisitions	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Business Combination Disclosure [Text Block]	'
	Note 13 – Business Acquisitions
	In August 2014, the Company acquired ECLI Products, LLC (“ECLI”), a specialty grease manufacturer for its North American reportable operating segment for approximately $52,000. ECLI specializes in greases for OEM first-fill customers across several industry sectors, including automotive, industrial, aerospace/military, electronics, office automation and natural resources. The Company allocated the purchase price to $31,110 of intangible assets, comprised of trademarks and formulations, to be amortized over 10 years; customer relationships, to be amortized over 15 years; and a non-compete agreement, to be amortized over 5 years. In addition, the Company recorded $13,429 of goodwill, all of which will be tax deductible. As of September 30, 2014, the allocation of the purchase price, highlighted in the table below, has not been finalized.
		2014 Acquisition		ECLI Products, LLC
		Current assets		$	6,908
		Fixed assets			2,712
		Intangibles			31,110
		Goodwill			13,429
			Total assets purchased		54,159
		Current liabilities			-2,159
			Total liabilities assumed		-2,159
		Cash paid for an acquisition		$	52,000
	Included in the ECLI acquisition was approximately $53 of cash acquired.
	In June 2014, the Company acquired the remaining 49% ownership interest in its Australian affiliate, Quaker Chemical (Australasia) Pty. Limited ("QCA") for Australian Dollars $8,000, or approximately $7,577, from its joint venture partner, Nuplex Industries. QCA is a part of the Asia/Pacific reportable operating segment. As this acquisition was a change in an existing controlling ownership, the Company recorded $6,450 of excess of purchase price over the carrying value of the noncontrolling interest in Additional Paid in Capital.
	In May 2013, the Company acquired a business that primarily related to tin plating for its North American reportable operating segment for net consideration of approximately $1,831. The Company allocated the purchase price to $830 of intangible assets, comprised of formulations, to be amortized over 10 years; a non-competition agreement, to be amortized over 4 years; and a customer list, to be amortized over 10 years. In addition, the Company recorded $277 of goodwill, all of which will be tax deductible. The remaining purchase price was allocated between the acquisition date fair value of inventory purchased of $454 and fixed assets purchased of $270.
	In January 2013, the Company acquired a chemical milling maskants distribution network for net consideration of approximately $647, which was assigned to the North America reportable operating segment. The Company also assumed an additional $100 hold-back of consideration for potential indemnity obligations, which was paid to the former shareholders during the first quarter of 2014. The acquired intangible was allocated to the Company's customer lists and rights to sell intangible assets and will be amortized over 5 years.
	Certain pro forma and other disclosures have not been provided for these acquisitions because the effects were not material.

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures [Text Block]	'
	Note 14 – Fair Value Measurements
	The Company values its company-owned life insurance policies, various deferred compensation assets and liabilities, and certain acquisition-related consideration at fair value. The Company's assets and liabilities subject to fair value measurement are as follows:
						Fair Value Measurements at September 30, 2014
			Fair Value			Using Fair Value Hierarchy
			as of
	Assets		30-Sep-14			Level 1			Level 2			Level 3
	Company-owned life insurance		$	1,323		$	0		$	1,323		$	0
	Company-owned life insurance - Deferred compensation assets			316			0			316			0
	Other deferred compensation assets
		Large capitalization registered investment companies		68			68			0			0
		Mid capitalization registered investment companies		6			6			0			0
		Small capitalization registered investment companies		12			12			0			0
		International developed and emerging markets registered investment
	companies			38			38			0			0
		Fixed income registered investment companies		6			6			0			0
	Total		$	1,769		$	130		$	1,639		$	0
						Fair Value Measurements at September 30, 2014
			Fair Value			Using Fair Value Hierarchy
			as of
	Liabilities		30-Sep-14			Level 1			Level 2			Level 3
	Deferred compensation liabilities
		Large capitalization registered investment companies	$	390		$	390		$	0		$	0
		Mid capitalization registered investment companies		102			102			0			0
		Small capitalization registered investment companies		85			85			0			0
		International developed and emerging markets registered investment
	companies			187			187			0			0
		Fixed income registered investment companies		40			40			0			0
		Fixed general account		158			0			158			0
	Total		$	962		$	804		$	158		$	0
						Fair Value Measurements at December 31, 2013
			Fair Value			Using Fair Value Hierarchy
			as of
	Assets		31-Dec-13			Level 1			Level 2			Level 3
	Company-owned life insurance		$	1,885		$	0		$	1,885		$	0
	Company-owned life insurance - Deferred compensation assets			409			0			409			0
	Other deferred compensation assets
		Large capitalization registered investment companies		74			74			0			0
		Mid capitalization registered investment companies		6			6			0			0
		Small capitalization registered investment companies		13			13			0			0
		International developed and emerging markets registered investment
	companies			40			40			0			0
		Fixed income registered investment companies		7			7			0			0
	Total		$	2,434		$	140		$	2,294		$	0
						Fair Value Measurements at December 31, 2013
			Fair Value			Using Fair Value Hierarchy
			as of
	Liabilities		31-Dec-13			Level 1			Level 2			Level 3
	Deferred compensation liabilities
		Large capitalization registered investment companies	$	405		$	405		$	0		$	0
		Mid capitalization registered investment companies		109			109			0			0
		Small capitalization registered investment companies		95			95			0			0
		International developed and emerging markets registered investment
	companies			205			205			0			0
		Fixed income registered investment companies		43			43			0			0
		Fixed general account		167			0			167			0
	Acquisition-related consideration			4,876			0			0			4,876
	Total		$	5,900		$	857		$	167		$	4,876
	The fair values of Company-owned life insurance (“COLI”) and COLI deferred compensation assets are based on quotes for like instruments with similar credit ratings and terms. The fair values of other deferred compensation assets and liabilities are based on quoted prices in active markets. The fair value of the Summit earnout was based on unobservable inputs and was classified as Level 3. At December 31, 2013, the significant input and assumption was the discount rate used to present value the liability. The fair value of the obligation related to a non-competition agreement was also based on unobservable inputs and was classified as Level 3. The significant inputs and assumptions for the obligation related to the non-competition agreement was management's estimate of the discount rate used to present value the liability. A significant change in any Level 3 assumption in isolation would have resulted in increases or decreases to the fair value measurements of the acquisition-related consideration.
	Changes in the fair value of the Level 3 liabilities during the nine months ended September 30, 2014 were as follows:
							Non-competition
				Earnout			Agreement
				Summit			Obligation			Total
		Balance at December 31, 2013		$	4,697		$	179		$	4,876
		Interest accretion		12			8			20
		Payments		-4,709			-187			-4,896
	Balance at September 30, 2014		$	0		$	0		$	0
The Company settled its obligation related to the Summit earnout liability with a payment of $4,709 to its former shareholders in April 2014. In addition, the Company made its final payment related to the non-competition agreement obligation in the third quarter of 2014.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments And Contingencies Disclosure [Abstract]	'
Commitments And Contingencies Disclosure [Text Block]	'
	Note 15 – Commitments and Contingencies
	In April of 1992, the Company identified certain soil and groundwater contamination at AC Products, Inc. (“ACP”), a wholly owned subsidiary. In voluntary coordination with the Santa Ana California Regional Water Quality Board (“SACRWQB”), ACP has been remediating the contamination, the principal contaminant of which is perchloroethylene (“PERC”). In 2004, the Orange County Water District (“OCWD”) filed a civil complaint against ACP and other parties seeking to recover compensatory and other damages related to the investigation and remediation of contaminated groundwater. Pursuant to a settlement agreement entered into by ACP and OCWD in 2007, ACP agreed, among other things, to operate two groundwater treatment systems to hydraulically contain groundwater contamination emanating from ACP's site until the concentrations of PERC released by ACP fell below the current Federal maximum contaminant level for four consecutive quarterly sampling events. In February of this year, ACP, with the consent of OCWD and SACRWQB, ceased operation at one of its two groundwater treatment systems, as it had met the above condition for closure. Based on the most recent modeling, it is estimated that the remaining system will operate for another fifteen months to three years.
	As of September 30, 2014, the Company believes that the range of potential-known liabilities associated with the balance of ACP water remediation program is approximately $425 to $1,050, for which the Company has sufficient reserves. This represents an increased range of estimated potential-known liabilities from prior reporting periods, as ACP has lengthened, by a year for the low end and by a year and three quarters for the high end, its expectation of meeting the settlement agreement's closure standards. The low and high ends of the range are based on the length of operation of the treatment system as determined by groundwater modeling. Costs of operation include the operation and maintenance of the extraction well, groundwater monitoring and program management.
	The Company believes, although there can be no assurance regarding the outcome of other unrelated environmental matters, that it has made adequate accruals for costs associated with other environmental problems of which it is aware. Approximately $171 and $205 was accrued at September 30, 2014 and December 31, 2013, respectively, to provide for such anticipated future environmental assessments and remediation costs.
	An inactive subsidiary of the Company that was acquired in 1978 sold certain products containing asbestos, primarily on an installed basis, and is among the defendants in numerous lawsuits alleging injury due to exposure to asbestos. The subsidiary discontinued operations in 1991 and has no remaining assets other than the proceeds from insurance settlements received. To date, the overwhelming majority of these claims have been disposed of without payment and there have been no adverse judgments against the subsidiary. Based on a continued analysis of the existing and anticipated future claims against this subsidiary, it is currently projected that the subsidiary's total liability over the next 50 years for these claims is approximately $2,700 (excluding costs of defense). Although the Company has also been named as a defendant in certain of these cases, no claims have been actively pursued against the Company, and the Company has not contributed to the defense or settlement of any of these cases pursued against the subsidiary. These cases were handled by the subsidiary's primary and excess insurers who had agreed in 1997 to pay all defense costs and be responsible for all damages assessed against the subsidiary arising out of existing and future asbestos claims up to the aggregate limits of the policies. A significant portion of this primary insurance coverage was provided by an insurer that is now insolvent, and the other primary insurers have asserted that the aggregate limits of their policies have been exhausted. The subsidiary challenged the applicability of these limits to the claims being brought against the subsidiary. In response, two of the three carriers entered into separate settlement and release agreements with the subsidiary in late 2005 and early 2007 for $15,000 and $20,000, respectively. The proceeds of both settlements are restricted and can only be used to pay claims and costs of defense associated with the subsidiary's asbestos litigation. During the third quarter of 2007, the subsidiary and the remaining primary insurance carrier entered into a Claim Handling and Funding Agreement, under which the carrier will pay 27% of defense and indemnity costs incurred by or on behalf of the subsidiary in connection with asbestos bodily injury claims for a minimum of five years beginning July 1, 2007. The agreement continues until terminated and can only be terminated by either party by providing the other party with a minimum of two years prior written notice. As of September 30, 2014, no notice of termination has been given under this agreement. At the end of the term of the agreement, the subsidiary may choose to again pursue its claim against this insurer regarding the application of the policy limits. The Company also believes that, if the coverage issues under the primary policies with the remaining carrier are resolved adversely to the subsidiary and all settlement proceeds were used, the subsidiary may have limited additional coverage from a state guarantee fund established following the insolvency of one of the subsidiary's primary insurers. Nevertheless, liabilities in respect of claims may exceed the assets and coverage available to the subsidiary.
	If the subsidiary's assets and insurance coverage were to be exhausted, claimants of the subsidiary may actively pursue claims against the Company because of the parent-subsidiary relationship. Although asbestos litigation is particularly difficult to predict, especially with respect to claims that are currently not being actively pursued against the Company, the Company does not believe that such claims would have merit or that the Company would be held to have liability for any unsatisfied obligations of the subsidiary as a result of such claims. After evaluating the nature of the claims filed against the subsidiary and the small number of such claims that have resulted in any payment, the potential availability of additional insurance coverage at the subsidiary level, the additional availability of the Company's own insurance and the Company's strong defenses to claims that it should be held responsible for the subsidiary's obligations because of the parent-subsidiary relationship, the Company believes it is not probable that the Company will incur any material losses. The Company has been successful to date having claims naming it dismissed during initial proceedings. Since the Company may be in this early stage of litigation for some time, it is not possible to estimate additional losses or range of loss, if any.
	As initially disclosed in the Company's second quarter 2010 Form 10-Q, one of the Company's subsidiaries may have paid certain value-added-taxes (“VAT”) incorrectly and, in certain cases, may not have collected sufficient VAT from certain customers. The VAT rules and regulations at issue are complex, vary among the jurisdictions and can be contradictory, in particular as to how they relate to the subsidiary's products and to sales between jurisdictions.
	Since its inception, the subsidiary had been consistent in its VAT collection and remittance practices and had never been contacted by any tax authority relative to VAT. The subsidiary later determined that for certain products, a portion of the VAT was incorrectly paid and that the total VAT due exceeds the amount originally collected and remitted by the subsidiary. In response, the subsidiary modified its VAT invoicing and payment procedures to eliminate or mitigate future exposures. In 2010, three jurisdictions contacted the subsidiary and, since then, the subsidiary has either participated in an amnesty program or entered into a settlement whereby it paid a reduced portion of the amounts owed in resolution of those jurisdictions' claims. In late 2013, an additional jurisdiction issued an assessment against the subsidiary for certain tax years. The subsidiary has filed an appeal of the assessment alleging certain errors by such jurisdiction related to the assessment.
	In analyzing the subsidiary's exposure, it is difficult to estimate both the probability and the amount of any potential liabilities due to a number of factors, including: the decrease in exposure over time due to applicable statutes of limitations and actions taken by the subsidiary, the joint liability of customers and suppliers for a portion of the VAT, the availability of a VAT refund for VAT incorrectly paid through an administrative process, any amounts which may have been or will be paid by customers, as well as the timing and structure of any tax amnesties or settlements. In addition, interest and penalties on any VAT due can be a multiple of the base tax. The subsidiary may contest any tax assessment administratively and/or judicially for an extended period of time, but may ultimately resolve its disputes through participation in tax amnesty programs, which are a common practice for settling tax disputes in the jurisdictions in question and which have historically occurred on a regular basis, resulting in significant reductions of interest and penalties. Also, the timing of payments and refunds of VAT may not be contemporaneous, and, if additional VAT is owed, it may not be fully recoverable from customers. As a result, this matter has the potential to have a material adverse impact on the Company's financial position, liquidity and capital resources and the results of operations.
	In 2010, the Company recorded a net charge of $4,132, which consisted of a net $3,901 charge related to two tax dispute settlements entered into by the subsidiary, as well as a net $231 charge representing management's best estimate based on the information available to it, including the factors noted above, of the amount that ultimately may be paid related to the other jurisdiction that has made inquiries. At September 30, 2014 and December 31, 2013, the Company had no remaining accrual, related to the 2010 charges for payments to be made under the tax dispute settlements entered into by the subsidiary, noted above. In the fourth quarter of 2013, the Company recorded a net charge of $796, representing the Company's best estimate that ultimately may be paid related to the 2013 assessment referenced above. This charge remains accrued and outstanding as of September 30, 2014.
	The charges taken by the Company in 2010 and in the fourth quarter of 2013 assume a successful recovery of the VAT incorrectly paid, as well as reductions in interest and penalties from anticipated future amnesty programs or settlements. On a similar basis, if all other potentially impacted jurisdictions were to initiate audits and issue assessments, the remaining exposure, net of refunds, could be from $0 to $7,800 with one jurisdiction representing approximately 84 percent of this additional exposure, assuming the continued availability of future amnesty programs or settlements to reduce the interest and penalties. If there are future assessments but no such future amnesty programs or settlements, the potential exposure could be higher.
	The Company is party to other litigation which management currently believes will not have a material adverse effect on the Company's results of operations, cash flows or financial condition.

Accounting_Policies_Policies

Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2014
Organization Consolidation And Presentation Of Financial Statements [Abstract]	'
Basis Of Accounting Policy [Policy Text Block]	'
	The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial reporting and the United States Securities and Exchange Commission regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments (consisting only of normal recurring adjustments, except as discussed below) which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. During the first quarter of 2014, the Company revised its Consolidated Balance Sheet for December 31, 2013 with a $335 reduction to retained earnings and a corresponding increase to its long-term deferred tax liability, relating to an adjustment that would have occurred when the Company adopted the equity method of accounting for its interest in a captive insurance equity affiliate. Certain other reclassifications of prior year data have been made to improve comparability. The results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company's Annual Report filed on Form 10-K for the year ended December 31, 2013.
Revenue Recognition Accounting Policy, Gross and Net Revenue Disclosure [Policy Text Block]	'
	As part of the Company's chemical management services, certain third-party product sales to customers are managed by the Company. Where the Company acts as the principal, revenue is recognized on a gross reporting basis at the selling price negotiated with customers. Where the Company acts as an agent, such revenue is recorded using net reporting as service revenues, at the amount of the administrative fee earned by the Company for ordering the goods.

Business_Segments_Tables

Business Segments (Tables)	9 Months Ended
	Sep. 30, 2014
Segment Reporting Measurement Disclosures [Abstract]	'
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
			Three Months Ended				Nine Months Ended
			September 30,				September 30,
			2014		2013		2014		2013
	Net sales
		North America	$	87,909	$	79,602	$	247,137	$	231,111
		EMEA		49,352		44,452		148,769		140,314
		Asia/Pacific		49,601		44,063		136,661		124,593
		South America		12,005		15,942		39,260		49,080
	Total net sales		$	198,867	$	184,059	$	571,827	$	545,098
	Operating earnings, excluding indirect operating expenses
		North America	$	17,771	$	15,203	$	51,350	$	46,238
		EMEA		8,589		6,781		24,794		22,332
		Asia/Pacific		11,925		11,214		32,064		31,612
		South America		883		2,598		3,281		7,830
	Total operating earnings, excluding indirect operating expenses			39,168		35,796		111,489		108,012
	Indirect operating expenses			-17,489		-16,131		-47,864		-49,380
	Amortization expense			-1,126		-858		-2,754		-2,621
	Consolidated operating income			20,553		18,807		60,871		56,011
	Other income (expense), net			914		-685		558		1,962
	Interest expense			-641		-717		-1,747		-2,223
	Interest income			642		267		1,990		665
	Consolidated income before taxes and equity in net income of associated companies		$	21,468	$	17,672	$	61,672	$	56,415

Stock_Based_Compensation_Table

Stock Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2014
Share Based Compensation [Abstract]	'
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]	'
				Three Months Ended						Nine Months Ended
				September 30,						September 30,
				2014			2013			2014			2013
		Stock options		$	171		$	140		$	492		$	378
		Nonvested stock awards and restricted stock units			593			461			1,758			1,372
		Employee stock purchase plan			18			17			54			43
		Non-elective and elective 401(k) matching contribution in stock			413			347			1,561			1,283
		Director stock ownership plan			32			16			94			57
		Total share-based compensation expense		$	1,227		$	981		$	3,959		$	3,133
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
									Weighted
									Average
					Weighted Average				Remaining
			Number of		Exercise Price per				Contractual
			Shares		Share				Term (years)
	Options outstanding at December 31, 2013		75,251		$	44.49
		Options granted	37,048			73.47
		Options exercised	-3,292			42.24
	Options outstanding at September 30, 2014		109,007		$	54.41				5.1
	Options exercisable at September 30, 2014		40,628		$	39.76				4
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	'
									Weighted		Weighted			Number	Weighted
							Number		Average		Average			Exercisable	Average
	Range of						Outstanding		Contractual		Exercise			at	Exercise
	Exercise Prices						at 9/30/2014		Life		Price			9/30/14	Price
	$	0	-		$	10	0		0		$	0		0	$	0
	$	10.01	-		$	20	6,155		2.3			18.82		6,155		18.82
	$	20.01	-		$	30	0		0			0		0		0
	$	30.01	-		$	40	35,020		4.1			37.87		23,954		37.75
	$	40.01	-		$	50	2,192		4.7			46.21		1,462		46.21
	$	50.01	-		$	60	28,592		5.4			58.26		9,057		58.26
	$	60.01	-		$	70	0		0			0		0		0
	$	70.01	-		$	80	37,048		6.4			73.47		0		0
							109,007		5.1			54.41		40,628		39.76
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
			2014
		Number of options granted	37,048
		Dividend yield	2	%
		Expected volatility	43.34	%
		Risk-free interest rate	1.22	%
		Expected term (years)	4
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	'
						Weighted
						Average Grant
				Number of		Date Fair Value
				Shares		(per share)
		Nonvested awards, December 31, 2013		115,984		$	47.27
			Granted	55,258		$	73.8
			Vested	-42,223		$	40.51
			Forfeited	-3,895		$	37.01
		Nonvested awards, September 30, 2014		125,124		$	61.59
						Weighted
						Average Grant
				Number of		Date Fair Value
				units		(per unit)
		Nonvested awards, December 31, 2013		4,018		$	49.71
			Granted	3,140		$	75.52
		Nonvested awards, September 30, 2014		7,158		$	61.03

Pension_and_Postretirement_Ben1

Pension and Postretirement Benefits (Tables)	9 Months Ended
	Sep. 30, 2014
General Discussion Of Pension And Other Postretirement Benefits [Abstract]	'
Schedule of Defined Benefit Plans Disclosures [Table Text Block]	'
		Three Months Ended September 30,								Nine Months Ended September 30,
						Other								Other
						Postretirement								Postretirement
		Pension Benefits				Benefits				Pension Benefits				Benefits
			2014		2013		2014		2013		2014		2013		2014		2013
	Service cost	$	716	$	789	$	5	$	9	$	2,186	$	2,355	$	15	$	26
	Interest cost and other		1,506		1,394		58		46		4,567		4,172		174		138
	Expected return on plan assets		-1,588		-1,476		0		0		-4,796		-4,417		0		0
	Actuarial loss amortization		763		989		16		8		2,311		2,961		48		24
	Prior service cost amortization		-21		23		0		0		830		155		0		0
	Net periodic benefit cost	$	1,376	$	1,719	$	79	$	63	$	5,098	$	5,226	$	237	$	188

Other_Income_Expense_Tables

Other Income (Expense) (Tables)	9 Months Ended
	Sep. 30, 2014
Other Income And Expenses [Abstract]	'
Schedule Of Other Nonoperating Income (Expense) [Table Text Block]	'
			Three Months Ended				Nine Months Ended
			September 30,				September 30,
			2014		2013		2014		2013
	Change in fair value of acquisition-related earnout liability		$	0	$	0	$	0	$	-675
	Cost streamlining initiative			0		-211		0		-211
	Income from third party license fees			181		168		736		716
	Net foreign currency exchange gains (losses)			160		-635		-824		-840
	Net gain on fixed asset disposals			25		29		130		267
	Non-income tax refunds			531		0		531		2,669
	Other non-operating income			88		27		152		193
	Other non-operating expense			-71		-63		-167		-157
		Total other income (expense), net	$	914	$	-685	$	558	$	1,962

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
			Three Months Ended				Nine Months Ended
				September 30,				September 30,
			2014		2013		2014		2013
	Basic earnings per common share
		Net income attributable to Quaker Chemical Corporation	$	15,696	$	12,551	$	43,853	$	42,253
		Less: income allocated to participating securities		-140		-109		-385		-358
		Net income available to common shareholders	$	15,556	$	12,442	$	43,468	$	41,895
		Basic weighted average common shares outstanding		13,133,668		13,062,417		13,114,553		13,034,289
	Basic earnings per common share		$	1.18	$	0.95	$	3.31	$	3.21
	Diluted earnings per common share
		Net income attributable to Quaker Chemical Corporation	$	15,696	$	12,551	$	43,853	$	42,253
		Less: income allocated to participating securities		-140		-109		-384		-357
		Net income available to common shareholders	$	15,556	$	12,442	$	43,469	$	41,896
		Basic weighted average common shares outstanding		13,133,668		13,062,417		13,114,553		13,034,289
		Effect of dilutive securities		22,673		22,488		21,147		25,909
		Diluted weighted average common shares outstanding		13,156,341		13,084,905		13,135,700		13,060,198
	Diluted earnings per common share		$	1.18	$	0.95	$	3.31	$	3.21

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2014
Goodwill And Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill [Table Text Block]	'
			North									South
			America			EMEA			Asia/Pacific			America			Total
	Balance as of December 31, 2013		$	28,127		$	11,184		$	15,018		$	3,822		$	58,151
		Goodwill additions		13,429			0			0			0			13,429
		Currency translation adjustments		-611			-341			-458			-117			-1,527
	Balance as of September 30, 2014		$	40,945		$	10,843		$	14,560		$	3,705		$	70,053
Schedule Of Finite Lived Intangible Assets [Table Text Block]	'
				Gross Carrying						Accumulated
				Amount						Amortization
		Definite-lived intangible assets		2014			2013			2014			2013
			Customer lists and rights to sell	$	53,894		$	33,559		$	11,812		$	10,221
			Trademarks and patents		6,628			6,838			3,628			3,202
			Formulations and product technology		15,338			5,808			3,968			3,709
			Other		6,540			5,544			4,791			4,445
			Total	$	82,400		$	51,749		$	24,199		$	21,577
Schedule of Finite Lived Intangible Assets Future Amortization Expense [TableText Block]	'
		For the year ended December 31, 2014	$	4,198
		For the year ended December 31, 2015	$	5,777
		For the year ended December 31, 2016	$	5,302
		For the year ended December 31, 2017	$	4,643
		For the year ended December 31, 2018	$	4,619
		For the year ended December 31, 2019	$	4,543

Equity_and_Noncontrolling_Inte1

Equity and Noncontrolling Interest (Tables)	9 Months Ended
	Sep. 30, 2014
Stockholders Equity [Abstract]	'
Schedule of Stockholders Equity [Table Text Block]	'
													Accumulated
							Capital in						Other
				Common			Excess of			Retained			Comprehensive		Noncontrolling
				Stock			Par Value			Earnings			Loss		Interest		Total
	Balance at June 30, 2014			$	13,242		$	95,508		$	279,161		$	-31,587	$	8,386	$	364,710
		Net income			0			0			15,696			0		423		16,119
		Amounts reported in other comprehensive income			0			0			0			-9,826		-246		-10,072
		Dividends ($0.30 per share)			0			0			-3,981			0		0		-3,981
		Distributions to noncontrolling affiliate shareholders			0			0			0			0		-1,149		-1,149
		Acquisition of noncontrolling interest			0			7			0			0		148		155
		Share issuance and equity-based compensation plans			27			1,039			0			0		0		1,066
		Excess tax benefit from stock option exercises			0			163			0			0		0		163
	Balance at September 30, 2014			$	13,269		$	96,717		$	290,876		$	-41,413	$	7,562	$	367,011
	Balance at June 30, 2013			$	13,168		$	97,085		$	238,580		$	-45,252	$	8,776	$	312,357
		Net income			0			0			12,551			0		754		13,305
		Amounts reported in other comprehensive income			0			0			0			2,014		-255		1,759
		Dividends ($0.25 per share)			0			0			-3,298			0		0		-3,298
		Distributions to noncontrolling affiliate shareholders			0			0			0			0		-30		-30
		Share issuance and equity-based compensation plans			19			368			0			0		0		387
		Excess tax benefit from stock option exercises			0			363			0			0		0		363
	Balance at September 30, 2013			$	13,187		$	97,816		$	247,833		$	-43,238	$	9,245	$	324,843
													Accumulated
							Capital in						Other
				Common			Excess of			Retained			Comprehensive		Noncontrolling
				Stock			Par Value			Earnings			Loss		Interest		Total
	Balance at December 31, 2013			$	13,196		$	99,038		$	258,285		$	-34,700	$	8,877	$	344,696
		Net income			0			0			43,853			0		1,517		45,370
		Amounts reported in other comprehensive income			0			0			0			-6,713		-47		-6,760
		Dividends ($0.85 per share)			0			0			-11,262			0		0		-11,262
		Distributions to noncontrolling affiliate shareholders			0			0			0			0		-1,806		-1,806
		Acquisition of noncontrolling interest			0			-6,443			0			0		-979		-7,422
		Share issuance and equity-based compensation plans			73			3,692			0			0		0		3,765
		Excess tax benefit from stock option exercises			0			430			0			0		0		430
	Balance at September 30, 2014			$	13,269		$	96,717		$	290,876		$	-41,413	$	7,562	$	367,011
	Balance at December 31, 2012			$	13,095		$	94,470		$	215,390		$	-41,855	$	8,576	$	289,676
		Net income			0			0			42,253			0		1,918		44,171
		Amounts reported in other comprehensive income			0			0			0			-1,383		-1,219		-2,602
		Dividends ($0.745 per share)			0			0			-9,810			0		0		-9,810
		Distributions to noncontrolling affiliate shareholders			0			0			0			0		-30		-30
		Share issuance and equity-based compensation plans			92			2,531			0			0		0		2,623
		Excess tax benefit from stock option exercises			0			815			0			0		0		815
	Balance at September 30, 2013			$	13,187		$	97,816		$	247,833		$	-43,238	$	9,245	$	324,843
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
									Unrealized
			Currency			Defined			gain (loss) in
			translation			benefit			available-for-
			adjustments			pension plans			sale securities			Total
	Balance at June 30, 2014		$	3,208		$	-36,274		$	1,479		$	-31,587
	Other comprehensive (loss) income before reclassifications			-11,409			1,698			-24			-9,735
	Amounts reclassified from accumulated other comprehensive loss			0			759			-300			459
	Current period other comprehensive (loss) income			-11,409			2,457			-324			-9,276
	Related tax amounts			0			-660			110			-550
	Net current period other comprehensive (loss) income			-11,409			1,797			-214			-9,826
	Balance at September 30, 2014		$	-8,201		$	-34,477		$	1,265		$	-41,413
	Balance at June 30, 2013		$	-1,646		$	-45,046		$	1,440		$	-45,252
	Other comprehensive income (loss) before reclassifications			2,527			-1,016			494			2,005
	Amounts reclassified from accumulated other comprehensive loss			0			1,019			-998			21
	Current period other comprehensive income (loss)			2,527			3			-504			2,026
	Related tax amounts			0			-183			171			-12
	Net current period other comprehensive income (loss)			2,527			-180			-333			2,014
	Balance at September 30, 2013		$	881		$	-45,226		$	1,107		$	-43,238
									Unrealized
			Currency			Defined			gain (loss) in
			translation			benefit			available-for-
			adjustments			pension plans			sale securities			Total
	Balance at December 31, 2013		$	1,152		$	-37,433		$	1,581		$	-34,700
	Other comprehensive (loss) income before reclassifications			-9,353			1,842			1,481			-6,030
	Amounts reclassified from accumulated other comprehensive loss			0			2,290			-1,959			331
	Current period other comprehensive (loss) income			-9,353			4,132			-478			-5,699
	Related tax amounts			0			-1,176			162			-1,014
	Net current period other comprehensive (loss) income			-9,353			2,956			-316			-6,713
	Balance at September 30, 2014		$	-8,201		$	-34,477		$	1,265		$	-41,413
	Balance at December 31, 2012		$	3,336		$	-46,914		$	1,723		$	-41,855
	Other comprehensive (loss) income before reclassifications			-2,455			-468			1,353			-1,570
	Amounts reclassified from accumulated other comprehensive loss			0			3,140			-2,286			854
	Current period other comprehensive (loss) income			-2,455			2,672			-933			-716
	Related tax amounts			0			-984			317			-667
	Net current period other comprehensive (loss) income			-2,455			1,688			-616			-1,383
	Balance at September 30, 2013		$	881		$	-45,226		$	1,107		$	-43,238

Business_Acquisitions_Tables

Business Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	'
		2014 Acquisition		ECLI Products, LLC
		Current assets		$	6,908
		Fixed assets			2,712
		Intangibles			31,110
		Goodwill			13,429
			Total assets purchased		54,159
		Current liabilities			-2,159
			Total liabilities assumed		-2,159
		Cash paid for an acquisition		$	52,000

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value, Assets Measured on Recurring Basis [Table Text Block]	'
						Fair Value Measurements at September 30, 2014
			Fair Value			Using Fair Value Hierarchy
			as of
	Assets		30-Sep-14			Level 1			Level 2			Level 3
	Company-owned life insurance		$	1,323		$	0		$	1,323		$	0
	Company-owned life insurance - Deferred compensation assets			316			0			316			0
	Other deferred compensation assets
		Large capitalization registered investment companies		68			68			0			0
		Mid capitalization registered investment companies		6			6			0			0
		Small capitalization registered investment companies		12			12			0			0
		International developed and emerging markets registered investment
	companies			38			38			0			0
		Fixed income registered investment companies		6			6			0			0
	Total		$	1,769		$	130		$	1,639		$	0
						Fair Value Measurements at December 31, 2013
			Fair Value			Using Fair Value Hierarchy
			as of
	Assets		31-Dec-13			Level 1			Level 2			Level 3
	Company-owned life insurance		$	1,885		$	0		$	1,885		$	0
	Company-owned life insurance - Deferred compensation assets			409			0			409			0
	Other deferred compensation assets
		Large capitalization registered investment companies		74			74			0			0
		Mid capitalization registered investment companies		6			6			0			0
		Small capitalization registered investment companies		13			13			0			0
		International developed and emerging markets registered investment
	companies			40			40			0			0
		Fixed income registered investment companies		7			7			0			0
	Total		$	2,434		$	140		$	2,294		$	0
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	'
						Fair Value Measurements at September 30, 2014
			Fair Value			Using Fair Value Hierarchy
			as of
	Liabilities		30-Sep-14			Level 1			Level 2			Level 3
	Deferred compensation liabilities
		Large capitalization registered investment companies	$	390		$	390		$	0		$	0
		Mid capitalization registered investment companies		102			102			0			0
		Small capitalization registered investment companies		85			85			0			0
		International developed and emerging markets registered investment
	companies			187			187			0			0
		Fixed income registered investment companies		40			40			0			0
		Fixed general account		158			0			158			0
	Total		$	962		$	804		$	158		$	0
						Fair Value Measurements at December 31, 2013
			Fair Value			Using Fair Value Hierarchy
			as of
	Liabilities		31-Dec-13			Level 1			Level 2			Level 3
	Deferred compensation liabilities
		Large capitalization registered investment companies	$	405		$	405		$	0		$	0
		Mid capitalization registered investment companies		109			109			0			0
		Small capitalization registered investment companies		95			95			0			0
		International developed and emerging markets registered investment
	companies			205			205			0			0
		Fixed income registered investment companies		43			43			0			0
		Fixed general account		167			0			167			0
	Acquisition-related consideration			4,876			0			0			4,876
	Total		$	5,900		$	857		$	167		$	4,876
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'
							Non-competition
				Earnout			Agreement
				Summit			Obligation			Total
		Balance at December 31, 2013		$	4,697		$	179		$	4,876
			Interest accretion		12			8			20
			Payments		-4,709			-187			-4,896
		Balance at September 30, 2014		$	0		$	0		$	0

Condensed_Financial_Informatio1

Condensed Financial Information (Details) (USD $)	3 Months Ended			9 Months Ended		12 Months Ended		3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2003	Dec. 31, 2013	Jun. 30, 2014	Mar. 31, 2013	Sep. 30, 2014	Mar. 31, 2014
								Kelko (Venezuela) [Member]	Kelko (Venezuela) [Member]	Kelko (Venezuela) [Member]	Primex [Member]
Schedule of Equity Method Investments [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Impact of Restatement on Opening Retained Earnings, Net of Tax	'	'	'	'	'	'	'	'	'	'	$335
Effect Of Currency Devaluation, Amount	'	'	'	'	'	'	'	'	357	'	'
Effect Of Currency Devaluation, Per Diluted Share	'	'	'	'	'	'	'	'	$0.03	'	'
Foreign Currency Transaction Gain (Loss), Realized	160	-635	'	-824	-840	'	'	321	'	'	'
Effect Of Currency Transaction Gain (Loss) Per Diluted Share	'	'	'	'	'	'	'	$0.02	'	'	'
Equity Method Investment	21,149	'	'	21,149	'	'	19,397	'	'	1,644	'
Other Nonoperating Expense	71	63	'	167	157	2,000	'	'	'	'	'
Mineral oil excise tax refund	'	'	2,057	'	'	'	'	'	'	'	'
Mineral oil excise tax refund, interest	'	'	483	'	'	'	'	'	'	'	'
Revenue Recognized Under Net Reporting Arrangements	$11,829	$10,950	'	$33,328	$30,288	'	'	'	'	'	'

Out_of_Period_Adjustment_Detai

Out of Period Adjustment (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2013
Accounting Changes and Error Corrections [Abstract]	'
Immaterial Error Correction	'During the first quarter of 2013, the Company identified errors in Primex’s estimated 2012 financial statements, which primarily related to a reinsurance contract held by Primex. The identified errors resulted in a cumulative $1,038 understatement of the Company’s equity in net income from associated companies for the year ended December 31, 2012. The Company corrected the errors related to Primex in the first quarter of 2013, which had the net effect of increasing equity in net income from associated companies by $1,038 for the three months ended March 31, 2013. The Company did not believe this adjustment was material to its consolidated financial statements for the years ended December 31, 2012 or December 31, 2013 and, therefore, did not restate any prior period amounts.
Amount of Error Correction	$1,038

Business_Segments_Details

Business Segments (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Segment Reporting Information [Line Items]	'	'	'	'
Net Sales	$198,867	$184,059	$571,827	$545,098
Operating Earnings, Excluding Indirect Operating Expenses	39,168	35,796	111,489	108,012
Reconciliation from Segment Totals to Consolidated [Abstract]	'	'	'	'
Indirect Operating Expenses	-17,489	-16,131	-47,864	-49,380
Amortization	-1,126	-858	-2,754	-2,621
Operating income	20,553	18,807	60,871	56,011
Other Income (Expense), net	914	-685	558	1,962
Interest Expense	-641	-717	-1,747	-2,223
Interest Income	642	267	1,990	665
Income Before Taxes and Equity in Net Income of Associated Companies	21,468	17,672	61,672	56,415
North America [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Net Sales	87,909	79,602	247,137	231,111
Operating Earnings, Excluding Indirect Operating Expenses	17,771	15,203	51,350	46,238
North America [Member] | Intersegment Sales Elimination [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Net Sales	2,605	2,486	6,411	7,333
EMEA [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Net Sales	49,352	44,452	148,769	140,314
Operating Earnings, Excluding Indirect Operating Expenses	8,589	6,781	24,794	22,332
EMEA [Member] | Intersegment Sales Elimination [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Net Sales	5,801	5,771	16,582	15,427
Asia Pacific [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Net Sales	49,601	44,063	136,661	124,593
Operating Earnings, Excluding Indirect Operating Expenses	11,925	11,214	32,064	31,612
Asia Pacific [Member] | Intersegment Sales Elimination [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Net Sales	127	58	329	363
South America [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Net Sales	12,005	15,942	39,260	49,080
Operating Earnings, Excluding Indirect Operating Expenses	883	2,598	3,281	7,830
South America [Member] | Intersegment Sales Elimination [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Net Sales	$0	$0	$0	$0

Stock_Based_Compensation_Expen

Stock Based Compensation - Expense Table (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Stock Options Compensation Expense	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	$171	$140	$492	$378
Nonvested Stock Awards and Restricted Stock Unit Compensation Expense	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	593	461	1,758	1,372
Employee Stock Purchase Plan Compensation Expense	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	18	17	54	43
401 (k) Matching Stock Contribution Plan Compensation Expense	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	413	347	1,561	1,283
Directors Stock Ownership Plan Compensation Expense	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	32	16	94	57
Total Share-based Compensation Expense	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	$1,227	$981	$3,959	$3,133

Stock_Based_Compensation_Narra

Stock Based Compensation - Narrative (Details) (USD $)	3 Months Ended	9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014
Share Based Compensation [Abstract]	'	'
Outstanding Options, Intrinsic Value	$2,007	$2,007
Exercisable Options, Intrinsic Value	1,330	1,330
Option Award Vesting Period	'	'3 years
Share Based Compensation [Line Items]	'	'
ESPP: Purchase Price Percentage	'	85.00%
ESPP: Discount from Market Price	'	15.00%
ESPP: Maximum Ownership of Outstanding Shares	'	'An employee whose stock ownership of the Company exceeds five percent of the outstanding common stock is not eligible to participate in this plan.
D S O P 2013 [Member]	'	'
Share Based Compensation [Line Items]	'	'
Director Stock Ownership Plan Maximum Number of Shares Authorized Under Plan	'	75,000
Director Stock Ownership Plan Terms	'	'Under the Plan, each director who, on May 1st of the applicable calendar year, owns less than 400% of the annual cash retainer for the applicable calendar year, divided by the average of the closing price of a share of Quaker Common Stock as reported by the composite tape of the New York Stock Exchange for the previous calendar year (the “Threshold Amount”), is required to receive 75% of the annual cash retainer in Quaker common stock and 25% of the retainer in cash, unless the director elects to receive a greater percentage of Quaker common stock (up to 100%) of the annual cash retainer for the applicable year. Each director who owns more than the Threshold Amount may elect to receive common stock in payment of a percentage (up to 100%) of the annual cash retainer.
Director Retainer Annual Fee	50	50
Options Granted in Current Year [Member]	'	'
Share Based Compensation [Line Items]	'	'
Share-based Compensation Expense in Period, Stock Option Awards	68	159
Unrecognized Share-Based Compensation Expense, Stock Option Awards	658	658
Options Granted in Previous Year [Member]	'	'
Share Based Compensation [Line Items]	'	'
Unrecognized Share-Based Compensation Expense, Stock Option Awards	304	304
Options Granted in Second Previous Year [Member]	'	'
Share Based Compensation [Line Items]	'	'
Unrecognized Share-Based Compensation Expense, Stock Option Awards	91	91
Restricted Stock LTIP Plan	'	'
Share Based Compensation [Line Items]	'	'
Unrecognized Share-based Compensation Expense, Nonvested Stock Award	4,916	4,916
Weighted Average Remaining Life, Nonvested Stock Awards	'	'2 years 4 months
Restricted Stock Units (RSUs) LTIP Plan	'	'
Share Based Compensation [Line Items]	'	'
Unrecognized Share-based Compensation Expense, Nonvested Stock Award	$243	$243
Weighted Average Remaining Life, Nonvested Stock Awards	'	'2 years

Stock_Based_Compensation_Exces

Stock Based Compensation - Excess Tax Benefit (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Share Based Compensation [Abstract]	'	'	'	'
Excess Tax Benefit From Stock Option Exercises	$163	$363	$430	$815
Excess Tax Benefit Related to Stock Option Exercises, Cash Flow	'	'	$430	$815

Stock_Based_Compensation_Optio

Stock Based Compensation - Options Grant (Details)	9 Months Ended	3 Months Ended
	Sep. 30, 2014	Mar. 31, 2014
		Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Options Granted	37,048	37,048
Dividend Yield	'	2.00%
Expected Volatility	'	43.34%
Risk-free Interest Rate	'	1.22%
Expected Term (Years)	'	'4 years

Stock_Based_Compensation_Optio1

Stock Based Compensation - Options Rollforward (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'
Beginning Balance	75,251
Options Granted	37,048
Options Exercised	-3,292
Ending Balance	109,007
Options Exerciseable	40,628
Weighted Average Exercise Price [Abstract]	'
Outstanding at Beginning of Year	$44.49
Options Granted	$73.47
Options Exercised	$42.24
Outstanding at End of Period	$54.41
Options Exercisable	$39.76
Weighted Average Contractual Term [Abstract]	'
Weighted Average Remaining Contractual Term, Outstanding	'5 years 1 month
Weighted Average Remaining Contractual Term, Exercisable	'4 years

Stock_Based_Compensation_Optio2

Stock Based Compensation - Options Summary (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
$0.00 - $10.00	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Range Limit	$0
Exercise Price Range, Upper Range Limit	$10
Number of Outstanding Options, Exercise Price Range	0
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	'0 years
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$0
Number of Exercisable Options, Exercise Price Range	0
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$0
$10.01 - $20.00	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Range Limit	$10.01
Exercise Price Range, Upper Range Limit	$20
Number of Outstanding Options, Exercise Price Range	6,155
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	'2 years 4 months
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$18.82
Number of Exercisable Options, Exercise Price Range	6,155
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$18.82
$20.01 - $30.00	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Range Limit	$20.01
Exercise Price Range, Upper Range Limit	$30
Number of Outstanding Options, Exercise Price Range	0
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	'0 years
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$0
Number of Exercisable Options, Exercise Price Range	0
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$0
$30.01 - $40.00	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Range Limit	$30.01
Exercise Price Range, Upper Range Limit	$40
Number of Outstanding Options, Exercise Price Range	35,020
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	'4 years 1 month
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$37.87
Number of Exercisable Options, Exercise Price Range	23,954
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$37.75
$40.01 - $50.00	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Range Limit	$40.01
Exercise Price Range, Upper Range Limit	$50
Number of Outstanding Options, Exercise Price Range	2,192
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	'4 years 8 months
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$46.21
Number of Exercisable Options, Exercise Price Range	1,462
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$46.21
$50.01 - $60.00	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Range Limit	$50.01
Exercise Price Range, Upper Range Limit	$60
Number of Outstanding Options, Exercise Price Range	28,592
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	'5 years 5 months
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$58.26
Number of Exercisable Options, Exercise Price Range	9,057
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$58.26
$60.01 - $70.00	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Range Limit	$60.01
Exercise Price Range, Upper Range Limit	$70
Number of Outstanding Options, Exercise Price Range	0
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	'0 years
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$0
Number of Exercisable Options, Exercise Price Range	0
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$0
$70.01 - $80.00	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Exercise Price Range, Lower Range Limit	$70.01
Exercise Price Range, Upper Range Limit	$80
Number of Outstanding Options, Exercise Price Range	37,048
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	'6 years 5 months
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$73.47
Number of Exercisable Options, Exercise Price Range	0
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$0
Total	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number of Outstanding Options, Exercise Price Range	109,007
Weighted Average Contractual Life, Outstanding Options, Exercise Price Range	'5 years 1 month
Weighted Average Exercise Price, Outstanding Options, Exercise Price Range	$54.41
Number of Exercisable Options, Exercise Price Range	40,628
Weighted Average Exercise Price, Exercisable Options, Exercise Price Range	$39.76

Stock_Based_Compensation_Restr

Stock Based Compensation - Restricted Stock Rollforward (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Restricted Stock [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]	'
Beginning Balance	115,984
Nonvested Stock Awards Granted	55,258
Nonvested Stock Awards Vested	-42,223
Nonvested Stock Awards Forfeited	-3,895
Ending Balance	125,124
Weighted Average Grant Date Fair Value, Nonvested Stock Awards, Beginning of Period	$47.27
Weighted Average Grant Date Fair Value, Nonvested Stock Awards Granted	$73.80
Weighted Average Grant Date Fair Value, Nonvested Stock Awards Vested	$40.51
Weighted Average Grant Date Fair Value, Nonvested Stock Awards Forfeited	$37.01
Weighted Average Grant Date Fair Value, Nonvested Stock Awards, End of Period	$61.59
Restricted Stock Units (RSUs) [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]	'
Beginning Balance	4,018
Nonvested Stock Awards Granted	3,140
Ending Balance	7,158
Weighted Average Grant Date Fair Value, Nonvested Stock Awards, Beginning of Period	$49.71
Weighted Average Grant Date Fair Value, Nonvested Stock Awards Granted	$75.52
Weighted Average Grant Date Fair Value, Nonvested Stock Awards, End of Period	$61.03

Pension_and_Postretirement_Ben2

Pension and Postretirement Benefits (Details) (USD $)	3 Months Ended			9 Months Ended		12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Mar. 31, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2014
Pension Plans, Defined Benefit [Member]	'	'	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'	'	'
Defined Benefit Plan, Service Cost	$716	'	$789	$2,186	$2,355	'
Defined Benefit Plan, Interest Cost	1,506	'	1,394	4,567	4,172	'
Defined Benefit Plan, Expected Return on Plan Assets	-1,588	'	-1,476	-4,796	-4,417	'
Defined Benefit Plan, Amortization of Losses	763	'	989	2,311	2,961	'
Defined Benefit Plan, Amortization of Prior Service Cost	-21	'	23	830	155	'
Defined Benefit Plan, Net Periodic Benefit Cost	1,376	'	1,719	5,098	5,226	'
Defined Benefit Plan, Expected Contributions In Current Fiscal Year	'	'	'	'	'	5,257
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year	'	'	'	'	'	6,172
Defined Benefit Plan, Contributions by Employer	'	'	'	4,757	'	'
Effect of Plan Amendment on Net Periodic Benefit Cost	'	902	'	'	'	'
Prior Service Cost Charge per Diluted Share	'	$0.05	'	'	'	'
Other Postretirement Benefit Plans, Defined Benefit [Member]	'	'	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'	'	'
Defined Benefit Plan, Service Cost	5	'	9	15	26	'
Defined Benefit Plan, Interest Cost	58	'	46	174	138	'
Defined Benefit Plan, Expected Return on Plan Assets	0	'	0	0	0	'
Defined Benefit Plan, Amortization of Losses	16	'	8	48	24	'
Defined Benefit Plan, Amortization of Prior Service Cost	0	'	0	0	0	'
Defined Benefit Plan, Net Periodic Benefit Cost	79	'	63	237	188	'
Defined Benefit Plan, Expected Contributions In Current Fiscal Year	'	'	'	'	'	607
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year	'	'	'	'	'	607
Defined Benefit Plan, Contributions by Employer	'	'	'	$432	'	'

Other_Income_Expense_Details

Other Income (Expense) - (Details) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2003
Other Income And Expenses [Abstract]	'	'	'	'	'
Change in Fair Value Estimate	$0	$0	$0	($675)	'
Licenses Revenue	181	168	736	716	'
Foreign Currency Transaction Gain (Loss), Realized	160	-635	-824	-840	'
Gain (Loss) On Disposition Of Assets	25	29	130	267	'
Proceeds From Non Income Tax Refunds	531	0	531	2,669	'
Impairment of Long-Lived Assets Held-for-Use	0	-211	0	-211	'
Other Nonoperating Income	88	27	152	193	'
Other Nonoperating Expense	-71	-63	-167	-157	-2,000
Other Income, Net	$914	($685)	$558	$1,962	'

Income_Taxes_and_Uncertain_Tax1

Income Taxes and Uncertain Tax Positions (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'	'	'	'	'	'
Effective Income Tax Rate, Continuing Operations	'	'	30.50%	30.00%	'	'
Effect on EPS of Uncertain Tax Position Adjustments	'	'	$0.06	$0.13	'	'
Unrecognized Tax Benefits	$11,317	'	$11,317	'	'	$12,596
Unrecognized Tax Benefits, Interest on Income Taxes Expense	-6	39	-64	-294	'	'
Unrecognized Tax Benefits, Income Tax Penalties Expense	-99	101	-1	342	'	'
Unrecognized Tax Benefits, Interest on Income Taxes Accrued	1,900	'	1,900	'	'	2,108
Unrecognized Tax Benefits, Income Tax Penalties Accrued	1,939	'	1,939	'	'	2,100
Tax Adjustments, Settlements, and Unusual Provisions	802	472	1,877	2,167	'	'
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Lower Bound	'	'	'	'	1,900	'
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound	'	'	'	'	$2,000	'
China [Member]	'	'	'	'	'	'
Income Tax Examination [Line Items]	'	'	'	'	'	'
Statutory Tax Rate	'	'	'	25.00%	'	'
Internal Revenue Service (IRS) [Member]	'	'	'	'	'	'
Income Tax Examination [Line Items]	'	'	'	'	'	'
Income Tax Examination Year Under Examination	'	'	'2011	'	'	'
Foreign Tax Authority [Member] | The Netherlands [Member]	'	'	'	'	'	'
Income Tax Examination [Line Items]	'	'	'	'	'	'
Income Tax Examination Year Under Examination	'	'	'2008	'	'	'
Foreign Tax Authority [Member] | United Kingdom [Member]	'	'	'	'	'	'
Income Tax Examination [Line Items]	'	'	'	'	'	'
Income Tax Examination Year Under Examination	'	'	'2009	'	'	'
Foreign Tax Authority [Member] | Brazil [Member]	'	'	'	'	'	'
Income Tax Examination [Line Items]	'	'	'	'	'	'
Income Tax Examination Year Under Examination	'	'	'2000	'	'	'
Foreign Tax Authority [Member] | Spain [Member]	'	'	'	'	'	'
Income Tax Examination [Line Items]	'	'	'	'	'	'
Income Tax Examination Year Under Examination	'	'	'2010	'	'	'
Foreign Tax Authority [Member] | China [Member]	'	'	'	'	'	'
Income Tax Examination [Line Items]	'	'	'	'	'	'
Income Tax Examination Year Under Examination	'	'	'2010	'	'	'
Foreign Tax Authority [Member] | Italy [Member]	'	'	'	'	'	'
Income Tax Examination [Line Items]	'	'	'	'	'	'
Income Tax Examination Year Under Examination	'	'	'2010	'	'	'
State and Local Jurisdiction [Member]	'	'	'	'	'	'
Income Tax Examination [Line Items]	'	'	'	'	'	'
Income Tax Examination Year Under Examination	'	'	'1993	'	'	'

Earnings_Per_Share_Basic_Detai

Earnings Per Share - Basic (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Per Share [Abstract]	'	'	'	'
Net Income Attributable to Quaker Chemical Corporation	$15,696	$12,551	$43,853	$42,253
Less: Income Allocated to Participating Securities	-140	-109	-385	-358
Net Income Available to Common Shareholders	$15,556	$12,442	$43,468	$41,895
Basic Weighted Average Common Shares Outstanding	13,133,668	13,062,417	13,114,553	13,034,289
Basic Earnings Per Common Share	$1.18	$0.95	$3.31	$3.21

Earnings_Per_Share_Diluted_Det

Earnings Per Share - Diluted (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Per Share [Abstract]	'	'	'	'
Net Income Attributable to Quaker Chemical Corporation	$15,696	$12,551	$43,853	$42,253
Less: Income Allocated to Participating Securities	-140	-109	-384	-357
Net Income Available to Common Shareholders	$15,556	$12,442	$43,469	$41,896
Basic Weighted Average Common Shares Outstanding	13,133,668	13,062,417	13,114,553	13,034,289
Effect of Dilutive Securities	22,673	22,488	21,147	25,909
Diluted Weighted Average Common Shares Outstanding	13,156,341	13,084,905	13,135,700	13,060,198
Diluted Earnings per Common Share	$1.18	$0.95	$3.31	$3.21

Earnings_Per_Share_Antidilutiv

Earnings Per Share - Antidilutive Shares (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Per Share [Abstract]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	6,146	2,858	5,254	4,118

Goodwill_Assets_Details

Goodwill Assets (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Goodwill [Roll Forward]	'
Goodwill, Beginning Balance	$58,151
Goodwill, Acquired During Period	13,429
Goodwill, Translation Adjustments	-1,527
Goodwill, Ending Balance	70,053
North America [Member]	'
Goodwill [Roll Forward]	'
Goodwill, Beginning Balance	28,127
Goodwill, Acquired During Period	13,429
Goodwill, Translation Adjustments	-611
Goodwill, Ending Balance	40,945
EMEA [Member]	'
Goodwill [Roll Forward]	'
Goodwill, Beginning Balance	11,184
Goodwill, Acquired During Period	0
Goodwill, Translation Adjustments	-341
Goodwill, Ending Balance	10,843
Asia Pacific [Member]	'
Goodwill [Roll Forward]	'
Goodwill, Beginning Balance	15,018
Goodwill, Acquired During Period	0
Goodwill, Translation Adjustments	-458
Goodwill, Ending Balance	14,560
South America [Member]	'
Goodwill [Roll Forward]	'
Goodwill, Beginning Balance	3,822
Goodwill, Acquired During Period	0
Goodwill, Translation Adjustments	-117
Goodwill, Ending Balance	$3,705

Intangible_Assets_Details

Intangible Assets (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets, Gross [Abstract]	'	'
Finite-Lived Customer Lists, Gross	$53,894	$33,559
Finite-Lived Trademarks, Gross	6,628	6,838
Formulations And Product Technology	15,338	5,808
Other Finite-Lived Intangible Assets, Gross	6,540	5,544
Total	82,400	51,749
Finite Lived Intangible Assets Accumulated Amortization [Abstract]	'	'
Finite Lived Intangible Assets Accumulated Amortization Customer Lists	11,812	10,221
Finite Lived Intangible Assets Accumulated Amortization Trademarks	3,628	3,202
Finite Lived Intangible Assets Accumulated Amortization Formulations	3,968	3,709
Finite Lived Intangible Assets Accumulated Amortization Other	4,791	4,445
Total	24,199	21,577
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]	'	'
For the year ended December 31, 2014	4,198	'
For the year ended December 31, 2015	5,777	'
For the year ended December 31, 2016	5,302	'
For the year ended December 31, 2017	4,643	'
For the year ended December 31, 2018	4,619	'
For the year ended December 31, 2019	4,543	'
Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]	'	'
Indefinite-Lived Trademarks	$1,100	$1,100

Intangible_Assets_Amortization

Intangible Assets - Amortization (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Goodwill And Intangible Assets Disclosure [Abstract]	'	'	'	'
Amortization	$1,126	$858	$2,754	$2,621

Debt_Narrative_Details

Debt - Narrative (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Debt Instrument [Line Items]	'	'
Line of Credit Facility, Covenant Terms	'Access to this facility is dependent on meeting certain financial, acquisition and other covenants, but primarily depends on the Company’s consolidated leverage ratio calculation, which cannot exceed 3.50 to 1.	'
Line of Credit [Member]	'	'
Debt Instrument [Line Items]	'	'
Line of Credit Facility Current Borrowing Capacity	$300,000	'
Line of Credit Facility Maximum Borrowing Capacity	400,000	'
Line Of Credit Maturity Date	'2018-06	'
Line of Credit Facility, Covenant Compliance	'At September 30, 2014 and December 31, 2013, the consolidated leverage ratio was below 1.0 to 1 and the Company was also in compliance with all of the facility’s other covenants.	'
Line of Credit Facility, Amount Outstanding	$45,000	$0

Equity_and_Noncontrolling_Inte2

Equity and Noncontrolling Interest (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Beginning Balance	$364,710	$312,357	$344,696	$289,676
Net Income	16,119	13,305	45,370	44,171
Amounts reported in other comprehensive income (loss)	-10,072	1,759	-6,760	-2,602
Dividends, Common Stock	-3,981	-3,298	-11,262	-9,810
Distributions to Noncontrolling Affiliate Shareholders	-1,149	-30	-1,806	-30
Acqusition of Noncontrolling Interest	155	0	-7,422	0
Share Issuance and Equity-Based Compensation Plans	1,066	387	3,765	2,623
Excess Tax Benefit From Stock Option Exercises	163	363	430	815
Ending Balance	367,011	324,843	367,011	324,843
Common Stock Member	'	'	'	'
Beginning Balance	13,242	13,168	13,196	13,095
Net Income	0	0	0	0
Amounts reported in other comprehensive income (loss)	0	0	0	0
Dividends, Common Stock	0	0	0	0
Distributions to Noncontrolling Affiliate Shareholders	0	0	0	0
Acqusition of Noncontrolling Interest	0	0	0	0
Share Issuance and Equity-Based Compensation Plans	27	19	73	92
Excess Tax Benefit From Stock Option Exercises	0	0	0	0
Ending Balance	13,269	13,187	13,269	13,187
Additional Paid-in Capital [Member]	'	'	'	'
Beginning Balance	95,508	97,085	99,038	94,470
Net Income	0	0	0	0
Amounts reported in other comprehensive income (loss)	0	0	0	0
Dividends, Common Stock	0	0	0	0
Distributions to Noncontrolling Affiliate Shareholders	0	0	0	0
Acqusition of Noncontrolling Interest	7	0	-6,443	0
Share Issuance and Equity-Based Compensation Plans	1,039	368	3,692	2,531
Excess Tax Benefit From Stock Option Exercises	163	363	430	815
Ending Balance	96,717	97,816	96,717	97,816
Retained Earnings [Member]	'	'	'	'
Beginning Balance	279,161	238,580	258,285	215,390
Net Income	15,696	12,551	43,853	42,253
Amounts reported in other comprehensive income (loss)	0	0	0	0
Dividends, Common Stock	-3,981	-3,298	-11,262	-9,810
Distributions to Noncontrolling Affiliate Shareholders	0	0	0	0
Acqusition of Noncontrolling Interest	0	0	0	0
Share Issuance and Equity-Based Compensation Plans	0	0	0	0
Excess Tax Benefit From Stock Option Exercises	0	0	0	0
Ending Balance	290,876	247,833	290,876	247,833
Accumulated Other Comprehensive Income (Loss) [Member]	'	'	'	'
Beginning Balance	-31,587	-45,252	-34,700	-41,855
Net Income	0	0	0	0
Amounts reported in other comprehensive income (loss)	-9,826	2,014	-6,713	-1,383
Dividends, Common Stock	0	0	0	0
Distributions to Noncontrolling Affiliate Shareholders	0	0	0	0
Acqusition of Noncontrolling Interest	0	0	0	0
Share Issuance and Equity-Based Compensation Plans	0	0	0	0
Excess Tax Benefit From Stock Option Exercises	0	0	0	0
Ending Balance	-41,413	-43,238	-41,413	-43,238
Noncontrolling Interest [Member]	'	'	'	'
Beginning Balance	8,386	8,776	8,877	8,576
Net Income	423	754	1,517	1,918
Amounts reported in other comprehensive income (loss)	-246	-255	-47	-1,219
Dividends, Common Stock	0	0	0	0
Distributions to Noncontrolling Affiliate Shareholders	-1,149	-30	-1,806	-30
Acqusition of Noncontrolling Interest	148	0	-979	0
Share Issuance and Equity-Based Compensation Plans	0	0	0	0
Excess Tax Benefit From Stock Option Exercises	0	0	0	0
Ending Balance	$7,562	$9,245	$7,562	$9,245

Equity_and_Noncontrolling_Inte3

Equity and Noncontrolling Interest - Parentheticals (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Stockholders Equity [Abstract]	'	'	'	'
Dividends Declared	$0.30	$0.25	$0.85	$0.75

Equity_and_Noncontrolling_Inte4

Equity and Noncontrolling Interest - Reclassifications (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Accumulated Other Comprehensive Loss, Balance at Beginning of Period	($31,587)	($45,252)	($34,700)	($41,855)
Other Comprehensive Income (Loss) Before Reclassifications	-9,735	2,005	-6,030	-1,570
Reclassifications From Accumulated Comprehensive Income Loss To Income Statement	459	21	331	854
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent	-9,276	2,026	-5,699	-716
Related Tax Amounts	-550	-12	-1,014	-667
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	-9,826	2,014	-6,713	-1,383
Accumulated Other Comprehensive Loss, Balance at End of Period	-41,413	-43,238	-41,413	-43,238
Accumulated Translation Adjustment [Member]	'	'	'	'
Accumulated Other Comprehensive Loss, Balance at Beginning of Period	3,208	-1,646	1,152	3,336
Other Comprehensive Income (Loss) Before Reclassifications	-11,409	2,527	-9,353	-2,455
Reclassifications From Accumulated Comprehensive Income Loss To Income Statement	0	0	0	0
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent	-11,409	2,527	-9,353	-2,455
Related Tax Amounts	0	0	0	0
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	-11,409	2,527	-9,353	-2,455
Accumulated Other Comprehensive Loss, Balance at End of Period	-8,201	881	-8,201	881
Accumulated Defined Benefit Plans Adjustment [Member]	'	'	'	'
Accumulated Other Comprehensive Loss, Balance at Beginning of Period	-36,274	-45,046	-37,433	-46,914
Other Comprehensive Income (Loss) Before Reclassifications	1,698	-1,016	1,842	-468
Reclassifications From Accumulated Comprehensive Income Loss To Income Statement	759	1,019	2,290	3,140
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent	2,457	3	4,132	2,672
Related Tax Amounts	-660	-183	-1,176	-984
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	1,797	-180	2,956	1,688
Accumulated Other Comprehensive Loss, Balance at End of Period	-34,477	-45,226	-34,477	-45,226
Accumulated Net Unrealized Investment Gain (Loss) [Member]	'	'	'	'
Accumulated Other Comprehensive Loss, Balance at Beginning of Period	1,479	1,440	1,581	1,723
Other Comprehensive Income (Loss) Before Reclassifications	-24	494	1,481	1,353
Reclassifications From Accumulated Comprehensive Income Loss To Income Statement	-300	-998	-1,959	-2,286
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent	-324	-504	-478	-933
Related Tax Amounts	110	171	162	317
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	-214	-333	-316	-616
Accumulated Other Comprehensive Loss, Balance at End of Period	$1,265	$1,107	$1,265	$1,107

Equity_and_Noncontrolling_Inte5

Equity and Noncontrolling Interest - Narrative (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Cost of Sales [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Reclassification Percentage	30.00%	30.00%	30.00%	30.00%
Operating Expense [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Reclassification Percentage	70.00%	70.00%	70.00%	70.00%

Business_Acquisitions_Table_De

Business Acquisitions - Table (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Mar. 31, 2013	Jun. 30, 2013	Sep. 30, 2014
In Thousands, unless otherwise specified			Socomor [Member]	Tin Plating [Member]	ECLI [Member]
Business Acquisition [Line Items]	'	'	'	'	'
Current Assets	'	'	'	'	$6,908
Inventory	'	'	'	454	'
Fixed Assets	'	'	'	270	2,712
Intangibles	'	'	'	830	31,110
Goodwill	70,053	58,151	'	277	13,429
Total Assets Acquired	'	'	'	'	54,159
Other Current Liabilities	'	'	'	'	-2,159
Business Acquisition, Purchase Price Allocation, Liabilities Assumed	'	'	'	'	-2,159
Business Acquisition, Cost of Acquired Entity, Purchase Price	'	'	$647	$1,831	$52,000

Business_Acquisitions_Narrativ

Business Acquisitions - Narrative (Details)

3 Months Ended

9 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

In Thousands, unless otherwise specified

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Socomor [Member]

Socomor [Member]

Tin Plating [Member]

Tin Plating [Member]

Tin Plating [Member]

Tin Plating [Member]

Australia [Member]

Australia [Member]

ECLI [Member]

ECLI [Member]

ECLI [Member]

ECLI [Member]

USD ($)

Customer Lists [Member]

USD ($)

Customer Lists [Member]

Noncompete Agreements [Member]

Formulations And Product Technology[Member]

USD ($)

AUD

USD ($)

Customer Lists [Member]

Noncompete Agreements [Member]

Trademarks [Member]

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash Paid for Acquisitions

'

'

$51,947

$2,478

'

'

'

'

'

'

'

$7,577

8,000

'

'

'

'

Goodwill

70,053

'

70,053

'

58,151

'

'

277

'

'

'

'

'

'

'

'

'

Intangibles

'

'

'

'

'

'

'

830

'

'

'

'

'

31,110

'

'

'

Intangible Assets, Amortizable Life

'

'

'

'

'

'

'5 years

'

'10 years

'4 years

'10 years

'

'

'

'15 years

'5 years

'10 years

Contingent Consideration Paid

'

'

4,709

0

'

100

'

'

'

'

'

'

'

'

'

'

'

Cash Acquired

'

'

'

'

'

'

'

'

'

'

'

'

'

53

'

'

'

Change in Fair Value Estimate

0

0

0

675

'

'

'

'

'

'

'

'

'

'

'

'

'

Minority Interest Ownership Percentage

'

'

'

'

'

'

'

'

'

'

'

49.00%

49.00%

'

'

'

'

Adjustments To Additional Paid In Capital Other

'

'

'

'

'

'

'

'

'

'

'

$6,450

'

'

'

'

'

Fair_Value_Measurements_Assets

Fair Value Measurements - Assets (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Total Fair Value Inputs [Member]	'	'
Cash Surrender Value, Fair Value Disclosure [Abstract]	'	'
Company Owned Life Insurance	$1,323	$1,885
Company Owned Life Insurance - Deferred Compensation Assets	316	409
Available-for-sale Securities, Fair Value Disclosure [Abstract]	'	'
Large Capitalization Registered Investment Companies	68	74
Mid Capitalization Registered Investment Companies	6	6
Small Capitalization Registered Investment Companies	12	13
International Developed And Emerging Markets Registered Investment Companies	38	40
Fixed Income Registered Investment Companies	6	7
Assets, Fair Value Disclosure	1,769	2,434
Fair Value, Inputs, Level 1 [Member]	'	'
Cash Surrender Value, Fair Value Disclosure [Abstract]	'	'
Company Owned Life Insurance	0	0
Company Owned Life Insurance - Deferred Compensation Assets	0	0
Available-for-sale Securities, Fair Value Disclosure [Abstract]	'	'
Large Capitalization Registered Investment Companies	68	74
Mid Capitalization Registered Investment Companies	6	6
Small Capitalization Registered Investment Companies	12	13
International Developed And Emerging Markets Registered Investment Companies	38	40
Fixed Income Registered Investment Companies	6	7
Assets, Fair Value Disclosure	130	140
Fair Value, Inputs, Level 2 [Member]	'	'
Cash Surrender Value, Fair Value Disclosure [Abstract]	'	'
Company Owned Life Insurance	1,323	1,885
Company Owned Life Insurance - Deferred Compensation Assets	316	409
Available-for-sale Securities, Fair Value Disclosure [Abstract]	'	'
Large Capitalization Registered Investment Companies	0	0
Mid Capitalization Registered Investment Companies	0	0
Small Capitalization Registered Investment Companies	0	0
International Developed And Emerging Markets Registered Investment Companies	0	0
Fixed Income Registered Investment Companies	0	0
Assets, Fair Value Disclosure	1,639	2,294
Fair Value, Inputs, Level 3 [Member]	'	'
Cash Surrender Value, Fair Value Disclosure [Abstract]	'	'
Company Owned Life Insurance	0	0
Company Owned Life Insurance - Deferred Compensation Assets	0	0
Available-for-sale Securities, Fair Value Disclosure [Abstract]	'	'
Large Capitalization Registered Investment Companies	0	0
Mid Capitalization Registered Investment Companies	0	0
Small Capitalization Registered Investment Companies	0	0
International Developed And Emerging Markets Registered Investment Companies	0	0
Fixed Income Registered Investment Companies	0	0
Assets, Fair Value Disclosure	$0	$0

Fair_Value_Measurements_Liabil

Fair Value Measurements - Liabilities (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Total Fair Value Inputs [Member]	'	'
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]	'	'
Large Capitalization Registered Investment Companies	$390	$405
Mid Capitalization Registered Investment Companies	102	109
Small Capitalization Registered Investment Companies	85	95
International Developed And Emerging Markets Registered Investment Companies	187	205
Fixed Income Registered Investment Companies	40	43
Fixed General Account	158	167
Acquisition-related Consideration	'	4,876
Liabilities, Fair Value Disclosure	962	5,900
Fair Value, Inputs, Level 1 [Member]	'	'
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]	'	'
Large Capitalization Registered Investment Companies	390	405
Mid Capitalization Registered Investment Companies	102	109
Small Capitalization Registered Investment Companies	85	95
International Developed And Emerging Markets Registered Investment Companies	187	205
Fixed Income Registered Investment Companies	40	43
Fixed General Account	0	0
Acquisition-related Consideration	'	0
Liabilities, Fair Value Disclosure	804	857
Fair Value, Inputs, Level 2 [Member]	'	'
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]	'	'
Large Capitalization Registered Investment Companies	0	0
Mid Capitalization Registered Investment Companies	0	0
Small Capitalization Registered Investment Companies	0	0
International Developed And Emerging Markets Registered Investment Companies	0	0
Fixed Income Registered Investment Companies	0	0
Fixed General Account	158	167
Acquisition-related Consideration	'	0
Liabilities, Fair Value Disclosure	158	167
Fair Value, Inputs, Level 3 [Member]	'	'
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]	'	'
Large Capitalization Registered Investment Companies	0	0
Mid Capitalization Registered Investment Companies	0	0
Small Capitalization Registered Investment Companies	0	0
International Developed And Emerging Markets Registered Investment Companies	0	0
Fixed Income Registered Investment Companies	0	0
Fixed General Account	0	0
Acquisition-related Consideration	'	4,876
Liabilities, Fair Value Disclosure	$0	$4,876

Fair_Value_Measurements_Level_

Fair Value Measurements - Level 3 Rollforward (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'	'
Change in Fair Value Estimate	$0	$0	$0	$675
Fair Value, Inputs, Level 3 [Member]	'	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'	'
Beginning Balance	'	'	4,876	'
Interest Accretion	'	'	20	'
Payments	'	'	-4,896	'
Ending Balance	0	'	0	'
Summit Earnout [Member] | Fair Value, Inputs, Level 3 [Member]	'	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'	'
Beginning Balance	'	'	4,697	'
Interest Accretion	'	'	12	'
Payments	'	'	-4,709	'
Ending Balance	0	'	0	'
Non-competition Agreement Obligation [Member] | Fair Value, Inputs, Level 3 [Member]	'	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'	'
Beginning Balance	'	'	179	'
Interest Accretion	'	'	8	'
Payments	'	'	-187	'
Ending Balance	$0	'	$0	'

Fair_Value_Disclosures_Quantit

Fair Value Disclosures - Quantitative Information (Details) (USD $)	3 Months Ended		9 Months Ended		3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2014
					Summit Earnout [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]	'	'	'	'	'
Change in Fair Value Estimate	$0	$0	$0	$675	'
Contingent Consideration Paid	'	'	$4,709	$0	$4,709

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Dec. 31, 2010	Dec. 31, 2010	Dec. 31, 2010	Dec. 31, 2013
In Thousands, unless otherwise specified			ACP [Member]	SB Decking [Member]	VAT, Total [Member]	VAT, Total [Member]	VAT Settlement One [Member]	VAT Settlement Two [Member]	VAT Assessment Three [Member]
Loss Contingencies [Line Items]	'	'	'	'	'	'	'	'	'
Gain (Loss) Related to Litigation Settlement	'	'	'	'	'	$4,132	$3,901	$231	'
Loss Contingency, Range of Possible Loss, Minimum	171	'	425	'	0	'	'	'	'
Loss Contingency, Range of Possible Loss, Maximum	'	205	1,050	'	7,800	'	'	'	'
P-2 Well Operation Range Estimate	'	'	'fifteen months to three years.	'	'	'	'	'	'
Loss Contingency Period Increase, High End	'	'	'a year and three quarters	'	'	'	'	'	'
Loss Contingency Period Increase, Low End	'	'	'a year	'	'	'	'	'	'
Loss Contingency, Estimate of Possible Loss	'	'	'	$2,700	'	'	'	'	$796
Loss Contingency, Settlement Agreement, Terms	'	'	'	' In response, two of the three carriers entered into separate settlement and release agreements with the subsidiary in late 2005 and early 2007 for $15,000 and $20,000, respectively. The proceeds of both settlements are restricted and can only be used to pay claims and costs of defense associated with the subsidiary’s asbestos litigation. During the third quarter of 2007, the subsidiary and the remaining primary insurance carrier entered into a Claim Handling and Funding Agreement, under which the carrier will pay 27% of defense and indemnity costs incurred by or on behalf of the subsidiary in connection with asbestos bodily injury claims for a minimum of five years beginning July 1, 2007. The agreement continues until terminated and can only be terminated by either party by providing the other party with a minimum of two years prior written notice. As of September 30, 2014, no notice of termination has been given under this agreement. At the end of the term of the agreement, the subsidiary may choose to again pursue its claim against this insurer regarding the application of the policy limits.	'	'	'	'	'
Percentage of Potential Exposure Represented by One Jurisdiction	'	'	'	'	84.00%	'	'	'	'